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ABSTRACT 
 
TRANSCRIPTIONAL CONTROL AND POPULATION DYNAMICS 
OF ANTIVIRAL CD8+ T CELL RESPONSES 
 
Michael A. Paley 
 
E. John Wherry, Ph.D. 
 
Cytotoxic lymphocytes are central components of cellular immune responses to 
intracellular pathogens and malignancy. The transcriptional programs that support 
proper population dynamics for lifelong immunity are incompletely understood. Two T-
box transcription factors, T-bet and Eomesodermin (Eomes), have critical roles in the 
development of natural killer cells and the differentiation of CD8+ T cells in response to 
acutely resolved infections. In both cases, these two factors support distinct but 
complementary cellular populations. In this thesis, we first used a recently generated 
reagent to examine and separate cellular populations with differential Eomes expression. 
We found that, while Eomes expression does not identify effector CD8+ T cells with 
enhanced cytotoxic potential, early Eomes expression does correlate with more efficient 
formation of long-lived, self-renewing central memory CD8+ T cells. This validated tool 
was then employed in our investigation into the population dynamics of CD8+ T cell 
responses during a chronic viral infection. While memory lymphocytes maintain lifelong 
immunity by slow self-renewal, chronic infections strain the regenerative capacity of 
antiviral T lymphocyte populations, leading to failure in long-term immunity. The cellular 
and molecular events controlling the regenerative capacity during chronic infection, 
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however, are unknown. We demonstrate that two distinct states of virus-specific CD8+ T 
cells exist in chronically infected mice and humans. The opposing properties of renewal 
and differentiation of these CD8+ T cell populations are supported by the differential 
expression of T-box transcription factors, which cooperatively maintain the pool of 
antiviral CD8+ T cells during chronic viral infection. T-bethi cells have low intrinsic 
turnover but proliferate in response to persisting antigen, giving rise to Eomeshi terminal 
progeny. Genetic elimination of either subset results in failure to control chronic infection, 
suggesting that imbalance in differentiation and renewal could underlie the collapse of 
immunity in humans with chronic infections. Furthermore, this work demonstrates new 
roles for T-bet and Eomes in CD8+ T cells regarding self-renewal and terminal 
differentiation, highlighting how T-box transcription factors can operate in exquisitely 
context-dependent manners. 
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CHAPTER 1: Introduction  
 
1.1 Viral challenges to human health 
Viral infections are a common challenge to the mammalian immune system. 
While many viral infections induce minimal disease in immunocompetent individuals, 
some viruses pose significant threats to worldwide health. For example in the United 
States, seasonal influenza averages 20,000 deaths every year as a result of acute 
infection (CDC, 2010). In contrast, other viruses, such as human immunodeficiency virus 
(HIV) or hepatitis C virus (HCV), establish a chronic infection and elicit disease over the 
ensuing years, each averaging 15,000 annual deaths (CDC, 2011; Ly et al., 2012). 
Therapies against HCV, while potentially curative, display low efficacy (Fried et al., 2002; 
Manns et al., 2001; McHutchison et al., 1998; McHutchison et al., 2009; Welsch et al., 
2012). In contrast, current medical interventions for HIV infection are not geared towards 
viral elimination, but rather are limited to reducing viral replication (Piacenti, 2006). 
Consequently, investigators continue to pursue other approaches that have the potential 
to synergize with or potentially replace current medical therapies. In particular, 
prophylactic or therapeutic interventions based on antiviral immune responses have 
demonstrated potential in this regard (Barber et al., 2006; Buchbinder et al., 2008; Diskin 
et al., 2011; Hansen et al., 2011; Rerks-Ngarm et al., 2009; Scheid et al., 2009; Scheid 
et al., 2011; Velu et al., 2009; Wei et al., 2010; Zhou et al., 2010). Nevertheless, it 
remains to be defined which components of the adaptive immune system are required to 
generate effective and broad immunity to each of these individual pathogens. 
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1.2 Adaptive immune responses 
While humoral immunity can provide an effective obstacle to establishment of a 
viral infection through antibody-mediated neutralization, clearance of an invading 
microbe depends on an effective response by the cellular arm of the adaptive immune 
system. In particular, CD8+ T cells fulfill a critical role due to their ability to recognize 
virally infected cells. This recognition is mediated by interactions between the T cell 
receptor (TCR) and components of degraded foreign viral proteins (8-10 amino acids in 
length) presented by the major histocompatibility complex (MHC) (Rock and Goldberg, 
1999). In this way, CD8+ T cells can recognize virally infected cells that may not display 
outward signs of infection. 
The importance of CD8+ T cell responses in controlling viral replication and 
subsequent disease has been implicated through examination of immunodeficient 
patients with susceptibility to viral infection and through genome-wide association 
studies after viral infection. For example, genetic mutations in the effector molecule 
perforin (discussed below) can impair both CD8+ T cell function and immune clearance 
of viral infection, leading to the inflammatory disorder termed hemophagocytic 
lymphohistiocytosis (HLH) (Jordan et al., 2004; Kogawa et al., 2002; Pachlopnik Schmid 
et al., 2009; Stepp et al., 1999). In addition, mutations in the receptor for IFN-gamma 
(discussed below), a major effector cytokine of CD8+ T cells, have been associated with 
severe viral infections, including herpes, parainfluenza, and respiratory syncytial viruses 
(Dorman et al., 1999). Similar to inherited or spontaneous mutations that lead to 
immunodeficiencies early in life, acquired immunosupression also illustrates the 
importance of CD8+ T cells in response to viral infections. For example, 
immunocompromised individuals due to HIV infection are at risk for clinical reactivation 
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of JC polyomavirus and subsequent progressive multifocal leukoencephalopathy (PML). 
In this setting, disease resolution was strongly associated with detectable antiviral CD8+ 
T cell responses (Du Pasquier et al., 2004). Thus, genetically impaired or 
immunologically poor CD8+ T cell responses have been suggested to lead to a variety of 
human disease states after viral infection. 
In parallel to these “experiments of nature,” genomic sequencing of 
polymorphisms has provided insight into individual genes that modulate control of or 
susceptibility to viral infection. For example during HIV infection, while several genes 
associated with co-receptor binding and viral entry, such as CCR5 and beta chemokines 
(CCL3-CCL5), have been linked to superior clinical outcomes, a number of MHC alleles 
have been associated with improved control of HIV replication, consistent with the 
hypothesis that CD8+ T cell responses are an essential component of the antiviral 
response (Chapman and Hill, 2012). Similarly, MHC alleles have also been associated 
with clearance or susceptibility to hepatitis B virus (HBV) (He et al., 2006) or enterovirus 
infection (Chang et al., 2008). Thus, the ability of CD8+ T cells to recognize virally 
infected target cells is associated with clinical protection against viral infection. 
1.3 CD8+ T cell responses 
Maintenance of virus-specific CD8+ T cell responses poses a unique challenge. 
Unlike other tissues with high rates of cellular replacement from long-lived progenitors, 
the CD8+ T cells that comprise antiviral responses may be genetically unique due to 
rearrangement of the TCR locus during thymic development (Koch and Radtke, 2011). 
In addition, these cells may have a low probability of replacement after age-associated 
thymic involution (Lynch et al., 2009). As a consequence, antiviral CD8+ T cells illustrate 
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a heightened tension between renewal (to preserve the unique TCR rearrangement) and 
terminal differentiation (to effectively mount an antiviral response). 
1.3.1 Initiation of antiviral CD8+ T cell responses 
After exposure to antigen, a naive CD8+ T cell initiates a phase of proliferation 
and differentiation to generate a large population of antiviral effector cells (Butz and 
Bevan, 1998; Murali-Krishna et al., 1998). CD8+ T cells mediate viral clearance through 
a variety of mechanisms. The most well-known effector function of “killer” T cells is the 
destruction of virally infected target cells. This cytotoxicity can be mediated by at least 
two separate mechanisms. The first is release of perforin, which forms a pore in the 
target cell membrane. The perforin pore leads to osmotic imbalances (Persechini et al., 
1990) and allows for entry of granzymes into the target cell inducing cell death (Trapani 
and Smyth, 2002). The second mechanism is mediated by the expression of Fas ligand 
and subsequent activation of the Fas death receptor pathway, leading to programmed 
cell death of the target cell (Kagi et al., 1994a; Kagi et al., 1994b; Lowin et al., 1994; 
Trapani and Smyth, 2002). In addition to direct cytotoxicity, CD8+ T cells also contribute 
to viral clearance through the release of proinflammatory cytokines, such as MIP-1alpha, 
IL-2, TNF-alpha, and IFN-gamma (Cocchi et al., 1995; Guidotti and Chisari, 1996). In 
particular, IFN-gamma plays a critical role in sensitizing target cells to cytolysis, 
enhancing antimicrobial activities of the innate immune system, and interfering with 
components of the viral life cycle (Schroder et al., 2004). 
1.3.2 Generation of lifelong CD8+ T cell memory after acutely resolved infections 
The population of terminal effector cells is short-lived and rapidly cleared after 
pathogen clearance (Joshi et al., 2007; Kaech et al., 2003; Murali-Krishna et al., 1998). 
A second population, however, persists after this contraction phase and matures into the 
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long-lived memory population that supports immunity in the case of pathogen re-
exposure. A number of events have been suggested to influence the development of this 
memory precursor population, including exposure to inflammatory signals (Joshi et al., 
2007), such as CpG (Pham et al., 2009), IL-2 (Manjunath et al., 2001; Pipkin et al., 
2010), and IL-12 (Takemoto et al., 2006), as well as asymmetric cell division (Chang et 
al., 2007).  
The events that regulate the evolution from memory precursors to long-lived 
memory cells, however, are less well understood. After the contraction phase, the initial 
surviving population of virus-specific cells has low expression of lymphoid homing 
markers (CD62L and CCR7) and resembles an effector memory T cell population 
(Wherry et al., 2003b). Over time, this population matures into a central memory pool 
that effectively homes to lymphoid organs and homeostatically self-renews (Wherry et 
al., 2003b). What signals regulate this maturation process is not well understood. 
One pathway that is known to influence the rate of memory maturation is the 
mammalian target of rapamycin (mTOR) pathway. Lose dose treatment with an inhibitor 
of the mTOR signaling cascade not only enhances the generation of memory precursor 
CD8+ T cells during the expansion phase, but also independently accelerates the 
memory precursor maturation towards central memory (Araki et al., 2009). The ability of 
rapamycin to enhance memory differentiation has been suggested to be due to changes 
in the expression of T-box transcription factors (discussed below) (Rao et al., 2010). 
1.3.3 Maintenance of lifelong CD8+ T cell memory to acutely resolved infections 
Once formed, memory T cells undergo slow homeostatic division in response to 
the homeostatic cytokines IL-7 and IL-15 (Becker et al., 2002; Goldrath et al., 2002; Tan 
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et al., 2002). This division is non-hierarchical as each long-lived memory cell has an 
equal probability of entering division (Choo et al., 2010) and has been suggested to 
predominantly occur in the bone marrow (Becker et al., 2005). In contrast, once memory 
cells encounter their cognate antigen, they proliferate and differentiate, giving rise to a 
population of short-lived cells that contribute to the anti-pathogen response (Ciocca et 
al., 2012; Dutton et al., 1998; Wherry et al., 2003b). At the same time, however, these 
activated memory cells renew the long-lived memory pool to ensure immunity in the 
event of future infection (Ciocca et al., 2012; Wherry et al., 2003b). In this way, memory 
T cells can effectively provide for lifelong protection against acutely resolved infections. 
1.3.4 Responses to persistent antigen and inflammation: CD8+ T cell exhaustion 
Chronic infections with high rates of pathogen replication as well as malignancy 
pose a different and perhaps more difficult challenge for maintaining anti-pathogen or 
anti-tumor responses. In contrast to acute infection, where the immune system returns to 
a state of quiescence after pathogen clearance, chronic infections and malignancy lead 
to sustained antigen and inflammation. How CD8+ T cells maintain such responses over 
years or decades has appeared paradoxical. 
CD8+ T cell responses to chronic viral infection in mice and humans have been 
characterized by their poor proliferative responses to in vitro antigenic stimulation 
(Migueles et al., 2002; Wherry et al., 2004; Zajac et al., 1998,Brenchley, 2003 #1353). 
Thus, it was possible that a prolonged antiviral (or anti-tumor) response was maintained 
by long-lived “exhausted” cells that have low rates of proliferation and cell turnover. 
Other investigators, however, have observed that exhausted CD8+ T cells have elevated 
rates of proliferation and cell turnover. For example, CD8+ T cells from chronically 
infected humans and mice display increased rates of apoptosis (Blackburn et al., 2010; 
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Gougeon et al., 1996; Lewis et al., 1994; Meyaard et al., 1992) which are matched by an 
extensive proliferative history (Brenchley et al., 2003), likely a result of high rates of cell 
turnover and in vivo proliferation (Hellerstein et al., 1999; Hellerstein et al., 2003; 
McCune et al., 2000; Sachsenberg et al., 1998; Shin et al., 2007). How to reconcile 
these discordant findings has remained unclear. Chapter 3 of this thesis will provide 
data to define the population dynamics of exhausted CD8+ T cell responses. 
A second feature of CD8+ T cell exhaustion is a reduction in effector functionality, 
such as cytotoxic potential and proinflammatory cytokine expression (Wherry, 2011). 
This dysfunction is associated with the upregulation of a variety of surface molecules, 
termed inhibitory receptors, which limit cytotoxic lymphocyte responses. Higher 
expression of a single inhibitory receptor (Blackburn et al., 2010; Day et al., 2006; 
Nakamoto et al., 2008) or enhanced co-expression of multiple of inhibitory receptors 
(Blackburn et al., 2009; Jin et al., 2010; Matsuzaki et al., 2010; McMahan et al., 2010; 
Nakamoto et al., 2009; Sakuishi et al., 2010) correlates with reduced CD8+ T cell effector 
function. In addition, blockade of a single (Barber et al., 2006; Brahmer et al., 2012; Day 
et al., 2006; Nakamoto et al., 2008; Raziorrouh et al., 2010; Topalian et al., 2012; Velu et 
al., 2009) or a combination (Blackburn et al., 2009; Jin et al., 2010; Matsuzaki et al., 
2010; McMahan et al., 2010; Nakamoto et al., 2009; Sakuishi et al., 2010; Zhou et al., 
2011) of inhibitory receptors restores CD8+ T cell function and leads to improved viral or 
tumor control.  
In addition to the expression of inhibitory receptors, immunoregulatory cytokines 
have also been implicated in the development of viral persistence and CD8+ T cell 
exhaustion. In particular, deletion or blockade of IL-10 (Brooks et al., 2008; Brooks et al., 
2006) or TGF-beta (Tinoco et al., 2009) has demonstrated these cytokines impede viral 
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elimination. Along with restoration of effector functions, most therapeutic interventions 
are associated with improved proliferation and expansion of antiviral or anti-tumor CD8+ 
T cell responses. Thus, whether the beneficial effects of therapeutic intervention are a 
result of enhanced quality of CD8+ T cell effector functions, expansion of the total CD8+ 
T cell population, or a combination thereof remains to be determined. Chapter 3 will 
provide a framework to understand how such interventions might influence the 
population dynamics of the CD8+ T cell response. 
1.4 T-box transcription factors  
Specification of differential cellular function and behavior is programmed through 
a network of transcriptional regulators. The family of T-box transcription factors, named 
after the founding member Brachyury (T), contributes to this specification during a 
diverse set of developmental processes, including trophoblast, limb, brain, heart, and 
immune cell differentiation (Naiche et al., 2005). The T-box family is defined by a 
conserved DNA binding domain that has been suggested to prefer the DNA consensus 
sequence TCACACCT (Naiche et al., 2005).  
1.4.1 Activity of T-box transcription factors is context-dependent  
T-box transcription factors regulate their target genes through a variety of 
mechanisms. T-box factors appear to be capable of both activation and repression of 
target genes. This differential activity appears to be dependent, in part, on other nuclear 
factors, such as histone methyltransferases (Lewis et al., 2007), suggesting that T-box 
factors may operate in a context-dependent manner. In support of this hypothesis, 
introduction of transcriptional repressors belonging to the Ripply or BTB-POZ family 
converts the activating activity of Tbx24 and T-bet (Tbx21) into repressive activity, 
respectively (Kawamura et al., 2008; Oestreich et al., 2011; Oestreich et al., 2012). 
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Furthermore, despite the apparent conserved binding affinity to the DNA consensus 
sequence and equivalent recruitment of histone methyltransferases by multiple family 
members, T-box factors still maintain cell-specific activity (Lewis et al., 2007). Thus, T-
box factors may be highly dependent on the co-expressed transcriptional network in 
order to appropriately regulate target genes. 
Oppositional activity of two related T-box family members was first hypothesized 
to occur between Tbx4 and Tbx5 in limb development. In the developing embryo, Tbx4 
and Tbx5 are expressed in the hindlimb and forelimb, respectively. Mutations in Tbx4 
lead to a human syndrome with lower limb deformities (Bongers et al., 2004), while 
mutations in Tbx5 lead to Holt-Oram syndrome with upper limb malformations (Basson 
et al., 1997; Li et al., 1997), suggesting that differential T-box factor expression 
conferred differential limb fate. Consistent with this hypothesis, inappropriate ectopic 
expression of Tbx4 or Tbx5 led to the development of hindlimbs or forelimbs, 
respectively, or features thereof (Rodriguez-Esteban et al., 1999; Takeuchi et al., 1999). 
Thus, two T-box factors may initiate and maintain distinct transcriptional programs within 
similar or analogous cell types. 
1.4.2 T-box factors regulate self-renewal and differentiation 
While T-box transcription factors have a variety of roles during embryogenesis 
and development, several family members also regulate tissue homeostasis in the adult 
organ. For example, Tbx1 regulates the renewal of long-lived progenitors in the hair 
follicle. Deletion of Tbx1 leads to an accelerated decline of these follicle stem cells after 
repeated regenerative stress (Chen et al., 2012). Other T-box family members regulate 
the development of terminally differentiated cells. For example, Eomesdermin (Eomes) 
supports the amplification and differentiation of neurons in the embryonic subventricular 
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zone (Arnold et al., 2008) and the adult dentate gyrus (Hodge et al., 2012).  Thus, T-box 
factors can support either long-lived, quiescent progenitors or short-lived, terminally 
differentiated progeny.  
1.4.3 T-box factors regulate antiviral immunity 
The two T-box factors that are expressed in immune cells are T-bet and 
Eomesodermin (Eomes). These two factors belong to the same T-box subfamily, which 
they share with T brain 1 (Tbr1) (Szabo et al., 2000). T-bet and Eomes share 74% 
identity in the T-box domain, but only 25% identity in the flanking C-terminal and N-
terminal regions (Pearce et al., 2003). While T-bet is expressed in a variety of immune 
cells associated with an antiviral Type 1 response (Lugo-Villarino et al., 2003; Sullivan et 
al., 2003; Szabo et al., 2000; Szabo et al., 2002; Townsend et al., 2004; Wang et al., 
2012), Eomes expression is largely restricted to cytotoxic lymphocytes (Pearce et al., 
2003) and potentially CD4+ T cells engaged in a Type 1 response (Qui et al., 2011; Suto 
et al., 2006; Yagi et al., 2010; Yang et al., 2008). One exception, however, may be a 
specific subpopulation of TH2 CD4+ T cells that express IL-5 (Endo et al., 2011). 
1.4.4 T-bet and Eomes in Natural Killer cells 
Natural killer (NK) lymphocyte development is initiated in the bone marrow with 
the generation of the NK precursor (NKp). Further progression through development to 
an intermediate stage is marked by the upregulation of NK cell antigens such as NK1.1 
and NKp46 as well as the death ligand TRAIL. While developmental arrest can occur at 
this stage, full NK cell maturation is associated with a proliferative burst and battery of 
phenotypic changes, including loss of TRAIL expression, upregulation of the 
inhibitory/activating Ly49 receptor family, induction of the integrins CD11b and CD49b, 
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and downmodulation of the costimulatory molecule CD27 (Gordon et al., 2012; 
Yokoyama et al., 2004). 
T-bet and Eomes are both expressed during this process; however, the exact 
role these factors play in NK cell development has recently been illuminated. In the 
absence of Eomes, NK cells arrest at the intermediate stage of differentiation, displaying 
expression of TRAIL with minimal CD49b expression. Eomes is also necessary for 
maintaining the stable program of fully mature NK cells, since temporal deletion of 
Eomes in CD49b+ NK cells leads to the loss of CD49b expression and the reacquisition 
of TRAIL expression (Gordon et al., 2012). Thus, Eomes plays a critical role specifically 
in this second stage of NK maturation. 
Unlike Eomes, T-bet appears to regulate earlier developmental steps. In the 
absence of T-bet, NK cells appear to have an accelerated developmental progression 
and lack cells that arrest at the intermediate TRAIL+ stage. In fact, temporal deletion of 
T-bet in intermediate NK cells leads to induction of Eomes expression and progression 
to a mature stage. Without either T-box factor, however, NK development does not 
progress past the NKp stage (Gordon et al., 2012). Thus, T-bet and Eomes appear to 
provide sequential specification during NK cell development. 
1.4.5 T-bet and Eomes in CD8+ T cells during acute infection 
In response to an acutely resolved infection, CD8+ T cells generate two 
populations of antiviral cells: short-lived, terminally differentiated effectors and long-lived, 
self-renewing memory. T-bet and Eomes appear to regulate the function, formation, and 
survival of both these populations. During the initial expansion after antigenic 
stimulation, T-bet and Eomes redundantly support cytotoxic effector programming 
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(Intlekofer et al., 2008; Zhu et al., 2010). This is likely a result of direct binding and 
transactivation of genes encoding cytotoxic molecules, such as perforin and granzyme 
B, and inflammatory cytokines, such as interferon gamma (Intlekofer et al., 2005 Cruz-
Guilloty, 2009 #807; Pearce et al., 2003; Pipkin et al., 2010; Townsend et al., 2004). 
Loss of both transcription factors leads to ineffective antiviral responses and aberrant 
differentiation to a Type 17 response (Intlekofer et al., 2008). T-bet and Eomes also 
redundantly support CD8+ T cell longevity through positive regulation of the beta chain of 
the IL-15 receptor, CD122. In particular, Eomes directly binds to the CD122 locus and 
activates gene expression (Intlekofer et al., 2005). 
T-bet and Eomes, however, also have opposing or alternative roles in CD8+ T 
cell responses to acutely resolved infection. Formation of terminally differentiated 
effector cells is dependent on the activity of T-bet (Intlekofer et al., 2007; Joshi et al., 
2007) but unaffected by the loss of Eomes (Banerjee et al., 2010). The expression of T-
bet during this process is regulated by environmental cues, such as CD4+ T cell help 
(Intlekofer et al., 2007), IL-12 signaling (Takemoto et al., 2006), and potentially other 
inflammatory signals (Joshi et al., 2007). The enhancement of the terminally 
differentiated population occurs at the expense of the memory precursor population 
(Intlekofer et al., 2007; Joshi et al., 2007; Takemoto et al., 2006). 
In contrast, Eomes supports the development or maintenance of long-lived, self-
renewing memory. Eomes expression is enriched in the memory pool after several 
months post viral clearance (Banerjee et al., 2010; Intlekofer et al., 2005) and genetic 
deletion of Eomes leads to a gradual decline in the memory population (Banerjee et al., 
2010). Eomes deficient memory cells also display poor expansion after antigenic 
challenge (Banerjee et al., 2010). The impaired maintenance is thought to be secondary 
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to poor homing to the bone marrow for homeostatic proliferation. Thus, T-bet and Eomes 
act redundantly to initiate effector programming, yet support alternative CD8+ T cell 
fates. Chapter 2 of this thesis will extend our understanding of when and how Eomes 
supports and directs the differentiation CD8+ T cells in response to acute viral infection. 
1.4.6 T-bet in CD8+ T cells during chronic infection 
The role for T-box factors in chronic viral infection is quite distinct from that of 
acutely resolved infection. Based on T-bet’s essential role in the formation of terminal 
effectors during the initial expansion, one might predict that T-bet expression would 
remain elevated as CD8+ T cells mount a prolonged antiviral response. After contraction 
of the short-lived population, however, T-bet expression in both mice (Kao et al., 2011) 
and humans (Hersperger et al., 2011; Ribeiro-Dos-Santos et al., 2012) is down-
regulated during chronic infection. The reduced expression of T-bet correlates with CD8+ 
T cell dysfunction, including lower perforin expression (Hersperger et al., 2011; Ribeiro-
Dos-Santos et al., 2012), poor viral control (Hersperger et al., 2011), and higher 
inhibitory receptor expression (Kao et al., 2011). Furthermore, genetic reduction in T-bet 
expression leads to enhanced inhibitory receptor expression, reduced cytokine 
expression, and an inability to sustain antiviral CD8+ T cell responses (Kao et al., 2011). 
Thus, higher T-bet expression is associated with more effective antiviral responses to 
chronic infections. Chapter 3 in this thesis will extend our understanding of the manner 
in which T-bet sustains antiviral responses during chronic viral infection. 
1.4.7 Eomes in CD8+ T cells during chronic infection 
Based on Eomes’ regulation of effective cytotoxic effector programming and 
maintenance of long-lived, protective memory, one could imagine that dysfunctional 
responses to chronic viral infections would be associated with lower Eomes expression. 
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Microarray analysis, however, has suggested that Eomes is elevated in exhausted CD8+ 
T cells (Wherry et al., 2007). Chapter 3 in this thesis will investigate the role for Eomes 
in this setting. 
1.5 The Lymphocytic Choriomeningitis Model of Viral Infection 
Lymphocytic Choriomeningitis Virus (LCMV) is a robust model of viral infection. 
Identified in 1934 by Charles Armstong (Beeman, 2007), LCMV is a negative sense, 
single stranded RNA virus belonging to the Arenaviridae family. Viral entry is mediated 
by GP1 protein of LCMV binding to alpha-dystroglycan on host cells, allowing for multi-
organ dissemination (Borrow and Oldstone, 1992; Cao et al., 1998). Clearance of viral 
infection requires an effective CD8+ T cell response (Jamieson et al., 1987; Moskophidis 
et al., 1987). Defects in CD8+ T cell effector functions have been demonstrated to impair 
viral clearance. For example, loss of IFN-gamma, Fas receptor activation, or perforin 
prevents effective viral control in LCMV-infected mice (Klavinskis et al., 1989; Leist et al., 
1989; Nansen et al., 1999; Rode et al., 2004; Wille et al., 1989). As a result, LCMV 
provides an effective model to test CD8+ T cell mediated viral control. 
1.5.1 Acutely resolved LCMV infection 
The initial strain of LCMV, named Armstrong after its discoverer Charles 
Armstrong (Beeman, 2007), initiates an acutely resolved infection. In adult mice, this 
virus replicates predominantly in the spleen, liver, and kidney and is normally cleared 
within 10 days with no manifestation of disease (Wherry et al., 2003a). LCMV Armstrong 
elicits potent adaptive immune responses that provide effective protection to 
rechallenge. Chapters 2 & 3 will use LCMV Armstrong to model CD8+ T cell responses 
to an acutely resolved viral infection. 
 
 
15 
1.5.2 Chronic LCMV infection 
In contrast to infection of adult mice, introduction of LCMV Armstong to neonatal 
mice leads to the development of a carrier state. These mice develop poor adaptive 
immune responses and are persistently infected with LCMV. A variant of LCMV 
Armstrong (clone 13) was isolated from the spleen of a carrier mouse. This variant was 
found to have acquired the capacity to persist in the adult host and establish a chronic 
infection (Ahmed et al., 1984). The ability of LCMV clone 13 to persist in the adult host 
was a result of two specific point mutations: one in the viral polymerase and one in the 
viral glycoprotein (Matloubian et al., 1993; Matloubian et al., 1990; Salvato et al., 1991; 
Sullivan et al., 2011). The mutation in the viral polymerase increases the polymerase 
activity and accelerates viral replication. The mutation in the viral glycoprotein increases 
the affinity of the viral glycoprotein for its receptor alpha-dystroglycan and broadens the 
tropism of the virus. Together, these two mutations are sufficient to convert LCMV from 
an acutely resolved infection to a chronic infection (Sullivan et al., 2011). Infection of 
immunocompetent mice with LCMV clone 13 leads to systemic viral replication with 
viremia lasting 2-3 months and lifelong viral reservoirs in the kidney and the brain 
(Wherry et al., 2003a). One benefit of the comparison between Armstrong and clone 13 
is that the adaptive immune recognition between these two variants is identical. Chapter 
3 of this thesis will employ this comparison to investigate transcriptional differences that 
arise due to viral persistence. Furthermore, Chapter 3 will use LCMV clone 13 as a 
robust model to investigate CD8+ T cell responses to viral infection. 
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CHAPTER 2: Fluorescent reporter reveals insights into 
Eomesodermin biology in cytotoxic lymphocytes 
 
2.1 Introduction: 
Cytotoxic lymphocytes play important roles in anti-viral and anti-tumor immune 
responses. Two major effector functions of NK and CD8+ T cells are the release of pro-
inflammatory cytokines and the killing of virally infected or transformed target cells via 
the perforin and granzyme pathway. These pathways are regulated by several 
transcription factors, including Eomesodermin (Eomes). However, Eomes has also been 
reported to regulate other essential features of cytotoxic cells. As a result, the relative 
importance of Eomes activity on effector functions versus differentiation remains 
obscure. 
Eomes supports a variety of differentiation events, ranging from mesoderm 
formation in the developing embryo (Russ et al., 2000) to lymphocyte differentiation in 
response to infection (Hertoghs et al., 2010; Intlekofer et al., 2008; Intlekofer et al., 
2005). In the hematopoetic system, Eomes has been reported to direct the differentiation 
of multiple lymphocyte subsets. For example, Eomes plays an important role in 
formation and maintenance of mature TRAIL-DX5+ NK cells (Gordon et al., 2012; 
Intlekofer et al., 2005; Tayade et al., 2005). In CD8+ T cells, Eomes has pleiotropic roles, 
supporting the developmental program of both effector (Intlekofer et al., 2008) and 
memory (Banerjee et al., 2010; Intlekofer et al., 2005) T cells. 
Eomes was identified in cytotoxic lymphocytes owing to its role in regulating 
expression of several effector molecules, e.g. IFN-γ, perforin, and granzyme B (Pearce 
 
 
17 
et al., 2003). Correspondingly, Eomes expression has been associated with enhanced 
CD8+ T cell cytotoxicity (Gao et al., 2005; Hegel et al., 2009; Hinrichs et al., 2008; 
Intlekofer et al., 2005; Pipkin et al., 2010; Rao et al., 2010; Tao et al., 2007) and anti-
viral (Intlekofer et al., 2008) and anti-tumor (Atreya et al., 2007; Gao et al., 2005; 
Hinrichs et al., 2008; Rao et al., 2010; Tao et al., 2007; Zhu et al., 2010) responses. 
Eomes expression has also been reported in cytotoxic CD4+ T cells and is essential for 
expression of granzyme B in these cells (Qui et al., 2011). Thus, Eomes is thought to be 
integral to the program of cytotoxic gene expression in multiple lymphocyte lineages and 
may provide an opportunity for therapeutic targeting.  
Consequently, CD8+ T cells that are induced or programmed to express high 
levels of Eomes would be predicted to have increased expression of effector molecules 
and enhanced lytic potential. Indeed, Eomes expression is heterogeneous within CD8+ T 
cell populations, displaying a large dynamic range (Banerjee et al., 2010; Gordon et al., 
2011). Whether CD8+ T cells with high Eomes expression produce more cytotoxic 
molecules and therefore exhibit higher cytolytic capacity than Eomes non-expressers 
has not been examined. 
Eomes expression is also particularly important for the maintenance of central 
memory CD8+ T cells (Banerjee et al., 2010), in part through its transcriptional regulation 
of the gene encoding IL-15Rβ (CD122), which enhances IL-15 responsiveness 
(Intlekofer et al., 2005). However, whether expression of Eomes during the expansion 
phase of the CD8+ T cell response is associated with improved formation or survival of 
central memory cells has not been determined. The initial Eomes reporter mouse 
required the addition of substrate in order to generate transient fluorescence (Intlekofer 
et al., 2005; Russ et al., 2000). A subsequent fluorescent protein-based construct with 
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spontaneous fluorescence grossly correlated with Eomes expression in the developing 
embryo (Kwon and Hadjantonakis, 2007), yet displayed incomplete fidelity in the 
developing brain (Arnold et al., 2009; Kwon and Hadjantonakis, 2007). A novel Eomes 
fluorescent reporter mouse, however, where GFP is expressed from the Eomes locus in 
lieu of Eomes more effectively paralleled Eomes expression (Arnold et al., 2009). Here, 
we report the validation and use of this Eomesgfp targeted allele in the study of Eomes 
gene expression in NK and CD8+ T cells.  
In CD8+ T cells, we were able to separate Eomes expressors (GFP+) from Eomes 
non-expressors (GFP-) by flow cytometry and address specific cytotoxic capacity of 
these subsets. Unexpectedly, Eomes expression was not associated with enhanced lytic 
potential in effector CD8+ T cells; however, early Eomes expression did correlate with 
improved central memory formation. Furthermore, examination of Eomesgfp expression 
in the absence of Eomes protein suggested that Eomes+ central memory CD8+ T cells 
may be dependent on Eomes expression for persistence. Lastly, reporter activity in 
Eomes-deficient NK cells allowed for the identification of putative intermediates in NK 
cell development that are primed for full maturation into TRAIL-DX5+ NK cells. Thus, the 
Eomesgfp targeted allele should provide a novel opportunity to further understand the role 
of Eomes in cytotoxic lymphocytes. 
 
2.2 Methods 
2.2.1 Mice and Infection: 
All animals were housed at the University of Pennsylvania (Philadelphia, PA). 
Experiments were performed in accordance with protocols approved by the University of 
Pennsylvania Institutional Animal Care and Use Committee. Eomesgfp/+ mice have been 
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described previously (Arnold et al., 2009). To study Eomes GFP reporter activity during 
Fas deficiency, Eomesgfp/+ mice were mated to Faslpr/lpr mice. To study Eomes GFP 
reporter activity in the absence of Eomes protein, Eomesgfp/+ mice were mated to 
Eomesflox/flox mice with or without CD4-Cre or Vav-Cre. To study Eomesgfp expression 
during anti-viral responses, mice were infected with 2 x 105 PFU of lymphocytic 
choriomenigitis virus (LCMV) Armstrong strain by i.p. injection. For some experiments, 
Eomesgfp/+ mice were also mated to P14 TCR-Tg mice to generate P14 Eomesgfp/+ mice. 
5 x 10^4 Eomesgfp/+ P14 CD8+ T cells (CD90.1) were transferred to WT B6 mice 
(CD90.2) 1 day prior to infection with LCMV Armstrong. 
2.2.2 Flow cytometry, division dye labeling, and real-time PCR: 
Surface and intracellular staining were performed as described previously 
(Gordon et al., 2011; Intlekofer et al., 2008). Antibodies used for flow cytometry were 
purchased from BD Biosciences (CD3, CD4, CD8, CD19, CD27, CD44, CD62L, CD122, 
DX5, NK1.1; San Jose, CA) or eBioscience (CD45.1, CD45.2, CD90.1, CD107a, CD127, 
Eomes, KLRG1, TRAIL; San Diego, CA). Intracellular staining for GFP was performed 
with polyclonal anti-GFP (eBioscience) followed by goat anti-rabbit Alexa Flour 488 
secondary (Invitrogen, Carlsbad, CA). Data were collected on a BD LSRII (BD 
Biosciences) and analyzed with FlowJo software (Tree Star, Ashland, OR). Cell sorting 
was performed using a BD Aria II (BD Biosciences). For indicated experiments, sorted 
cells were subsequently labeled with CellTrackerTM Violet (Invitrogen) according to 
manufacturer’s instructions. qRT-PCR was carried out as previously described 
(Intlekofer et al., 2008). Target gene probes were purchased from Applied Biosystems 
(Foster City, CA). 
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2.2.3 Cytotoxicity assay: 
Splenocytes from wild-type CD45.1 mice were labeled with two different 
concentrations (50 nM = “dim” or 2 µM = “bright”) of carboxyfluorescein diacetate 
succinimidyl ester (CFSE) (Invitrogen).  CFSEdim target splenocytes were incubated with 
LCMV-derived NP396-404 peptide, while CFSEbright control splenocytes were incubated 
with ovalbumin-derived SIINFEKL peptide for 1h at 37°C. 5x103 target cells were mixed 
with 5x103 control cells. GFP+ and GFP- CD8+ T cells from d8 LCMV-infected mice were 
separated by cell sorting and percentages of GFP+ and GFP- NP396-specifc CD8+ T 
cells were determined by flow cytometry after tetramer staining.  Increasing doses of 
GFP+ and GFP- NP396-specifc CD8+ T cells were added to wells containing target and 
control cells.  Unlabeled, wildtype CD45.2 CD57BL/6 splenocytes were used to 
normalize cell concentrations in each well.  After 6 or 24 hr incubation at 37°C, target cell 
destruction was assessed by flow cytometry. % specific lysis was calculated as 100 * [1 
– (% target cell remaining / % control cell remaining)]. 
 
2.3 Results 
2.3.1 Expression of Eomesgfp is largely restricted to cytotoxic lineages and correlates 
with Eomes protein expression. 
Eomes expression has been reported in a variety of cell types during different 
stages of lymphocyte differentiation. We first validated whether expression of Eomesgfp 
faithfully matched Eomes expression by correlating GFP expression with previous 
reports of Eomes mRNA or protein. 
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In the hematopoietic system, Eomes is expressed predominantly in cytotoxic 
lymphocytes (Pearce et al., 2003). We therefore determined whether Eomesgfp 
expression followed a similar distribution within leukocyte lineages. In Eomesgfp/+ mice, 
NK and CD8+ T cells contained the highest frequency of GFP+ cells, while GFP 
expression in CD4+ T cells, B cells, and other lymphocyte lineages remained low or 
undetectable (Fig 2.1A). The small population of GFP+ CD4+ T cells may represent a 
recently described subset of memory TH2 cells (Endo et al., 2011). In other blood cells, 
such as monocyte and granulocyte populations, GFP expression was undetectable (data 
not shown).  
As GFP expression was heterogeneous in NK and CD8+ T cells (Fig 2.1A), we 
examined whether Eomesgfp activity matched previous reports of Eomes protein 
expression in different CD8+ T cell subsets. We have recently identified an important role 
for Eomes in the generation of central memory CD8+ T cells (Banerjee et al., 2010). 
Consistent with Eomes protein expression (Banerjee et al., 2010), central memory 
phenotype (CD44hiCD62Lhi) CD8+ T cells (Tcm) from unmanipulated mice exhibited a 
high frequency of GFP expression, whereas naïve (CD44lo) and effector memory 
phenotype (CD44hiCD62Llo) CD8+ T cells (Tem) had lower frequency of GFP expression 
(Fig 2.1B). Notably, a minority of central memory phenotype CD8+ T cells remained 
GFP-. We therefore hypothesized that Eomes might regulate a subset of central memory 
phenotype CD8+ T cells. 
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Figure 2.1. Expression of Eomesgfp is largely restricted to cytotoxic lineages and 
correlates with Eomes protein expression. 
Flow cytometry of GFP expression in indicated subpopulations of (A) mature 
splenocytes and (B) splenic CD8+ T cells from unmanipulated Eomes+/+ (filled 
histograms) and Eomesgfp/+(open histograms) mice. (C) GFP expression positively 
correlates with a target of Eomes, CD122, in central memory CD8+ T cells. Flow 
cytometry of CD122 versus GFP expression in effector and central memory phenotype 
CD8+ T cells. Numbers denote frequency within the gated population. 
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The beta chain for the IL-15 receptor (CD122), a direct target of Eomes 
(Intlekofer et al., 2005), is important for homeostasis of memory CD8+ T cells by 
supporting basal homeostatic proliferation (Becker et al., 2002; Goldrath et al., 2002; 
Tan et al., 2002). We therefore examined whether Eomesgfp expression correlated with a 
known Eomes transcriptional target in memory CD8+ T cells. Effector memory phenotype 
CD8+ T cells expressed low levels of both GFP and CD122. In contrast, central memory 
phenotype CD8+ T cells expressed high levels of CD122 and GFP, with a high frequency 
of GFP and CD122 co-expression (Fig 2.1C). Thus, the Eomesgfp targeted allele 
matches Eomes protein expression and trans-activation by Eomes. 
2.3.2 GFP expression quantitatively parallels Eomes protein expression. 
We next addressed whether activity of the Eomesgfp locus matched quantitative 
changes in Eomes protein expression. Mice and humans with mutations in Fas or FasL 
suffer from autoimmune and lymphoproliferative syndrome (ALPS). A major feature of 
ALPS is lymphadenopathy and splenomegaly due to the accumulation of αβ TCR-
bearing CD4−CD8− (double-negative [DN]) T cells. These DN T cells express substantial 
levels of Eomes and Eomes expression is critical for their accumulation (Kinjyo et al., 
2010). We chose to employ this model of Fas deficiency to examine whether activity of 
the Eomesgfp locus would quantitatively match enhanced Eomes protein expression. 
Examination of NK, CD4+, CD8+, and DN T cells from FasWT/WT Eomesgfp/+ mice revealed 
that GFP+ cells in each population expressed similar amounts of GFP per cell as 
measured by MFI of GFP+ cells (Fig 2.2A). In Faslpr/lpr Eomesgfp/+ mice, however, CD4+ 
and CD8+ T cells exhibited a 1.5 fold enhancement of GFP expression over NK cells, 
while DN T cells demonstrated greater than 2-fold increase in GFP expression (Fig 
2.2A). The fold enrichment of GFP expression paralleled increases in Eomes protein  
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Figure 2.2. GFP expression quantitatively matches Eomes protein expression.  
Flow cytometry of (A) GFP or (B) Eomes protein expression in indicated splenic 
subpopulations from Eomes+/+ (filled histograms) and Eomesgfp/+(open histograms) mice 
with indicated Fas genotype. Numbers denote GFP MFI and Eomes MFI of GFP+ and 
Eomes+ cells, respectively. (C) GFP expression is specific for Eomes expression in 
lymphocytes. Flow cytometry of intracellular staining for Eomes and GFP protein in NK 
and central memory CD8+ T cells from Eomes+/+ and Eomesgfp/+ mice. 
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expression (Fig 2.2B). Thus, the dynamic range of Eomes expression in DN T cells 
during ALPS is primarily regulated at the transcriptional level. In addition, the activity of 
the Eomesgfp locus can discriminate between quantitative changes in Eomes protein 
levels. 
To further confirm that Eomesgfp expression correlates with Eomes protein 
expression in NK and CD8+ T cells, we directly compared Eomes and GFP protein 
levels. GFP fluorescence is lost upon fixation and permeabilization for Eomes protein 
staining due to direct quenching of fluorescence, loss of GFP protein from the cell, or a 
combination thereof. As a result, we measured GFP expression by directly staining for 
GFP protein using an anti-GFP antibody followed by an Alexa Flour 488 conjugated 
secondary antibody. Intracellular staining revealed a positive correlation between Eomes 
and GFP protein expression, as all GFP+ cells were Eomes+ (Fig 2.2C). Of note, a 
fraction of both NK and CD8+ T cells expressed Eomes protein without immunologic 
detection of GFP protein (Fig 2.2C). Consequently, Eomesgfp locus activity may be a 
specific, but not entirely sensitive, reporter of Eomes protein expression in lymphocyte 
populations.  
2.3.3 Eomes expression does not identify the most cytotoxic effector CD8+ T cells. 
Eomes has been reported to transcriptionally activate several genes associated 
with cytotoxic capacity, such as those encoding perforin and granzyme B protein 
(Pearce et al., 2003; Pipkin et al., 2010). Furthermore, in vitro culture conditions that 
induce heightened expression of Eomes in CD8+ T cells are associated with more potent 
cytotoxicity than those conditions resulting in lower Eomes (Pipkin et al., 2010). 
However, direct analysis of whether Eomes expression leads to enhanced cytotoxic 
potential is lacking. To this end, Eomesgfp/+ reporter mice were infected with lymphocytic 
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choriomeningitis virus (LCMV) Armstrong to assess whether Eomes expression 
correlates with enhanced cytotoxicity in effector CD8+ T cells.  
We first examined whether Eomesgfp expression enriched for terminal effector or 
memory precursor cells. We have previously reported that Eomes protein is equally 
distributed between these two subsets (Banerjee et al., 2010). Consistent with our 
previous observations, virus-specific GFP+ and GFP- CD8+ T cells displayed equal 
expression of terminal effector markers such as KLRG1 and memory markers such as 
CD127 or CD27 (Fig 2.3A). 
To determine whether Eomes expression conferred enhanced cytolytic potential, 
we assessed whether Eomes expression was associated with enhanced degranulation 
and increased expression of cytotoxic molecules. As peptide stimulation leads to TCR 
downregulation and loss of tetramer staining, we utilized cells from P14 TCR transgenic 
mice, where we could track virus-specific cells by congenic markers. Eomesgfp/+ P14 
CD8+ T cells were isolated one week post-infection and stimulated with cognate peptide. 
GFP+ and GFP- P14 CD8+ T cells displayed equal levels of degranulation as measured 
by CD107a (LAMP-1) staining (Fig 2.3B). We next evaluated whether Eomes 
expression led to enhanced transcription of cytotoxic molecules. Eomesgfp/+ P14 CD8+ T 
cells from LCMV-infected mice were sorted based on GFP expression. Comparison of 
GFP+ and GFP- effector CD8+ T cells revealed a modest reduction in the expression of 
granzyme B and perforin mRNA in GFP+ cells compared to GFP- cells, although this 
trend was not statistically significant (Fig 2.3C).  
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Figure 2.3. Eomes expression does not correlate with enhanced cytotoxicity. 
Endogenous or P14 Eomesgfp/+ CD8+ T cell responses were assessed after LCMV 
infection. (A) GFP expression in CD8+ T cells is not biased towards terminal effector or 
memory precursor cells. GFP+ and GFP- np396-specific CD8+ T cells were assessed for 
KLRG1, CD127, and CD27 expression 8 days post-infection. (B) Eomes expression 
does not correlate with enhanced degranulation. Eomesgfp/+ P14 CD8+ T cells were 
stimulated with or without Dbgp33-41 peptide 7 days post-infection. Degranulation was 
assessed by CD107a staining. (C) Eomes expression does not correlate with enhanced 
transcription of cytotoxic molecules. Eomesgfp/+ P14 CD8+ T cells were sorted based on 
GFP expression 7 days post-infection and assessed for Perforin and Granzyme B 
mRNA expression. mRNA levels were normalized to HPRT and are reported relative to 
naïve cells. (n.s.; Wilcoxon matched pairs test). (D) Cytolytic activity of GFP+ and GFP- 
CD8+ T cells. Sorted GFP+ and GFP- CD8+ T cells were equalized for NP396-specific 
CD8+ T cells and added to target cells pulsed with LCMV-derived peptide NP396-404. % 
specific lysis was determined by the loss of target cells compared to control cells. 
Graphs displays mean ± S.E.M. 
 
 
 
29 
Last, we determined whether Eomes expression influenced the cytotoxic 
potential of effector CD8+ T cells. Sorted GFP+ and GFP- CD8+ T cells displayed 
equivalent cytotoxicity on a per cell basis in an in vitro killing assay (Fig 2.3D). Thus, 
while Eomes may activate genes encoding cytotoxic molecules early after T cell 
activation in vitro, Eomes expression does not correlate with enhanced cytotoxicity in 
fully differentiated in vivo generated effector T cells. Consequently, robust killing may be 
independent of Eomes expression at this stage of the CD8+ T cell response. 
2.3.4 Progressive enrichment of Eomes expression in memory CD8+ T cells. 
Compared to effector CD8+ T cells at the peak of cellular expansion, memory 
CD8+ T cells have elevated Eomes expression (Banerjee et al., 2010; Intlekofer et al., 
2005). Whether this elevated expression is due to selection of Eomes+ memory CD8+ T 
cells, gradual induction of Eomes expression in Eomes- memory CD8+ T cells, or a 
combination of the two is unclear. To assess whether Eomes enrichment is due to 
selection or induction, we first examined GFP expression longitudinally in virus-specific 
Eomesgfp/+ CD8+ T cells after infection with LCMV. 
As noted above, GFP expression was elicited in virus-specific CD8+ T cells at the 
peak of expansion (d8). During the contraction phase, however, a consistent reduction in 
GFP expression was observed (d8-d15) (Fig 2.4A). Nevertheless, as the memory 
population matured (d15-d60), GFP expression was progressively enriched (Fig 2.4A), 
consistent with elevated Eomes expression in late virus-specific memory (Banerjee et 
al., 2010; Intlekofer et al., 2005). 
As Eomes expression is important for central memory CD8+ T cells (Banerjee et 
al., 2010), it is possible that expression of Eomes early after activation would lead to 
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enhanced memory formation (Rao et al., 2010), however this hypothesis has not been 
formally examined. To determine whether early Eomes expression correlates with the 
formation of long-lived, Eomes+ CD8+ T cells, P14 Eomesgfp/+ CD8+ T cells were sorted 
based on relative GFP expression 8 days post-infection and transferred into infection-
matched controls. While analysis of GFP expression revealed a modest downregulation 
of Eomes in the first week after viral clearance, 80-90% of GFP+ cells retained Eomes 
expression (Fig 2.4B, 2.5A). In contrast, GFP- cells largely remained GFP-  (Fig 2.4B, 
2.5A). Thus, the majority of Eomes expression in the memory population appears to 
arise during the initial phase of the antiviral response. 
We next tested whether early Eomes expression was associated with improved 
memory differentiation. P14 Eomesgfp/+ CD8+ T cells that were separated by GFP 
expression at day 8 post-infection gave rise to equal numbers of memory cells, with a 
modest trend towards enhanced homing to the bone marrow (Fig 2.5B). The CD8+ T cell 
population with early Eomes expression, however, did mature more rapidly to central 
memory, as measured by the expression of CD62L (Fig 2.5C, D). Thus, while early 
Eomes expression may not be associated with enhanced survival into the memory 
phase, early induction of the Eomes locus correlates with more efficient central memory 
formation. 
2.3.5 Expression of the Eomes locus is reduced in the absence of Eomes protein. 
We next evaluated whether CD8+ T cells stably transcribe the Eomes locus in the 
absence of Eomes protein. To test this, we generated Eomesgfp/flox mice with or without 
Cre recombinase under the control of the CD4 promoter (CD4-Cre).  
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Figure 2.4. Progressive enrichment of Eomes expression in memory CD8+ T cells. 
Endogenous or P14 Eomesgfp/+ CD8+ T cell responses were assessed after LCMV 
infection. (A) Induction of Eomes expression is biphasic. Longitudinal GFP expression in 
gp33-specific CD8+ T cells from the blood of Eomesgfp/+ mice at indicated days post-
infection. (B) Early expression of Eomes is predominantly stable. Eomesgfp/+ P14 CD8+ T 
cells were sorted based on GFP expression 8 days post-infection and transferred into 
infection-matched controls. Plots display GFP expression of sorted populations in the 
blood at indicated days post-infection. Numbers indicate frequencies within gated 
populations. Graph displays mean ± S.E.M. 
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Figure 2.5. Early expression of Eomes is associated with more efficient central 
memory generation. Eomesgfp/+ P14 CD8+ T cells were sorted based on GFP 
expression 8 days post-infection and transferred into infection-matched controls as in 
Fig 2.4B. (A) Plots display GFP expression of sorted populations recovered from blood, 
spleen and bone marrow 45 days post-transfer (53 days post-infection).  (B) Total P14 
Eomesgfp/+ CD8+ T cells recovered in (A). (C) CD62L expression of sorted populations 
from (A). (D) Quantification of %CD62Lhi and CD62L MFI of CD62Lhi cells from (C). 
Numbers indicate frequencies within gated populations. Graphs display mean ± S.E.M. 
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Eomesgfp/flox mice contain a high frequency of CD8+ T cells with a phenotype of 
long-lived, self-renewing central memory, e.g. expressing L-selectin (CD62L) and 
components of the IL-15R (CD122) and IL-7R (CD127) (Fig 2.5; left column). 
Consistent with a role for Eomes in the support of central memory CD8+ T cell 
differentiation (Banerjee et al., 2010), a majority of these central memory phenotype 
CD8+ T cells express GFP (Fig 2.5; left column). Deletion of Eomes led to reduced 
expression of all three markers of long-lived memory CD8+ T cells and to a reduced 
frequency of GFP+ cells (Fig 2.5; right column). In particular, less than of quarter of 
CD62Lhi, CD122hi, or CD127hi CD8+ T cells maintained GFP expression in the absence 
of Eomes protein (Fig 2.5; right column). Quantification of GFP+ and GFP- central 
memory phenotype CD8+ T cells suggested that the lower GFP expression was due to 
specific loss of the Eomes+ subset rather than reduced Eomes locus activity (Fig 2.5B).  
In the absence of Eomes, central memory CD8+ T cells fail to maintain a long-
lived, stable population, presumably due to decreased homeostatic proliferation as a 
result of reduced bone marrow homing (Banerjee et al., 2010). To determine whether the 
specific loss of GFP+ central memory phenotype CD8+ T cells resulted from poor 
homeostatic proliferation, we sorted GFP+ CD44hi CD62Lhi CD8+ T cells from Eomesgfp/flox 
mice with or without CD4-Cre, labeled the cells with a cell proliferation dye (Violet Cell 
TrackerTM), and transferred them into congenically disparate hosts. Analysis of cell 
division after one month in vivo demonstrated reduced homeostatic proliferation in 
Eomes-deficient CD8+ T cells (Fig 2.6A). Thus, central memory CD8+ T cells that 
activate Eomes transcription also become dependent upon Eomes protein for 
persistence. 
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Figure 2.6. Central memory cells with an active Eomes locus are reduced in the 
absence of Eomes protein. (A) Flow cytometry of CD62L, CD122, and CD127 versus 
GFP expression in splenic CD44hi CD8+ T cells from mice with indicated genotype. 
Numbers denote frequency of cells in each quadrant. Eomes protein expression is also 
shown for the Cre-negative (open) and Cre-positive (filled) populations. (B) Total GFP- 
and GFP+ central memory (CD44hi CD62Lhi) cells in the presence (Cre-negative; open) 
or absence (Cre-positive; filled) of Eomes protein. (C) Sorted GFP+ central memory 
(CD44hi CD62Lhi) cells were labeled with a cell division dye (CellTrackerTM Violet) and 
transferred into CD45.1 congenic recipients. Plots display GFP expression versus 
CellTrackerTM Violet after 4 weeks in vivo.  
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2.3.6 Eomesgfp allows for detection of putative intermediates of NK cell development. 
TRAIL+DX5- NK cells appear to represent developmental intermediates of NK cell 
maturation.  Adoptive transfer of TRAIL+DX5- NK cells has been shown to generate 
TRAIL-DX5+ NK cells in recipient mice (Gordon et al., 2012; Takeda et al., 2005). 
Deletion of Eomes, however, prevents NK cells from progressing past the TRAIL+DX5- 
precursor stage (Gordon et al., 2012). Whether TRAIL+DX5- NK cells activate Eomes 
expression prior to the maturation into TRAIL-DX5+ NK cells is not known. To investigate 
whether Eomes transcriptional activation occurs prior to maturation, we examined 
Eomesgfp activity in NK cells in the presence or absence of Eomes protein.  
We first determined that GFP expression correlated with markers of NK 
maturation. In Eomesgfp/+ mice, GFP expression was restricted to TRAIL-DX5+ NK cells 
(Fig 2.7A), consistent with Eomes protein expression (Gordon et al., 2012). In the 
absence of Cre, Eomesgfp/flox NK cells are able to express one functional copy of Eomes 
and appropriately generate a high frequency population of TRAIL- DX5+ NK cells that 
express both GFP and Eomes protein (Fig 2.7B,C; left column). As expected, NK cells 
from Eomesgfp/flox mice harboring Cre had a severe reduction in the frequency of mature 
TRAIL-DX5+ NK cells and a selective enrichment for TRAIL+DX5- precursors (Fig 
2.7B,C; right column). Nevertheless, Eomes deficient NK cells contained a small 
population of cells that expressed high levels of both GFP and TRAIL (Fig 2.7B; top 
row). The dual expression of GFP and TRAIL suggests that a population of TRAIL+DX5- 
precursors receive differentiation signals and activate Eomes transcription in the initial 
stages of the development of mature NK cells. 
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Figure 2.7. Eomesgfp allows for detection of putative intermediates of NK cell 
development. (A) GFP is predominantly expressed in mature TRAIL- DX5+ NK cells. 
Flow cytometry of TRAIL, DX5 and GFP expression in liver NK cells. (B) Flow cytometry 
of TRAIL or DX5 versus GFP or Eomes protein expression in liver NK cells from mice 
with indicated genotype. Numbers denote frequency of cells in each quadrant. 
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2.4 Discussion 
In this study, we described the GFP expression of an Eomesgfp targeted allele in 
the adult leukocyte compartment and matched Eomes and GFP expression in mature 
lymphocytes. While Eomes expression did not segregate with differential cytotoxicity in 
effector CD8+ T cells, early Eomes expression did lead to more efficient central memory 
formation. In addition, central memory CD8+ T cells that activate the Eomes locus may 
become dependent on Eomes protein for persistence and homeostatic proliferation. 
Lastly, GFP expression in Eomes-deficient NK cells enabled the identification of a 
putative intermediate of NK cell development. 
Retroviral-based overexpression of Eomes appears to initiate a cytotoxic 
transcriptional program, activating effector genes such as IFN-γ, granzyme B, and 
perforin (Cruz-Guilloty et al., 2009; Pearce et al., 2003; Pipkin et al., 2010). Furthermore, 
in cultures with high IL-2 concentration, higher expression of Eomes correlates with 
CD8+ T cell killing capacity (Hinrichs et al., 2008; Pipkin et al., 2010). However, whether 
the enhanced killing capacity is a direct result of increased Eomes expression was not 
addressed. With the availability of an Eomesgfp reporter, we were able to separate cells 
with high Eomes expression from cells with negative or low Eomes expression within the 
same population. We found that higher Eomes expression did not correlate with higher 
expression of the cytotoxic molecules granzyme B and perforin nor with enhanced 
cytotoxicity in fully differentiated effector CD8+ T cells. One possible resolution to this 
paradox is that Eomes may play a more important role earlier, in acquiring cytotoxic 
potential, rather than in exerting cytotoxic function. Alternatively, the equivalent cytotoxic 
molecule expression and cytotoxicity of GFP+ and GFP- subsets may be due to the 
redundancy of other transcription factors at this stage of the CD8+ T cell response. In 
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particular, the T-box factor T-bet plays a redundant role with Eomes in the induction of 
the cytotoxic program in effector CD8+ T cells (Intlekofer et al., 2008). Indeed, previous 
work indicates that deletion of Eomes did not appreciably affect the killing capacity of 
effector CD8+ T cells (Intlekofer et al., 2008).  
Other transcription factors may also contribute to cytotoxic gene expression in 
the absence of Eomes. Notch (Cho et al., 2009) and Runx3 (Cruz-Guilloty et al., 2009) 
can both bind to the granzyme B and perforin loci and activate their transcription. In 
addition, differential signaling through Akt can modulate perforin expression without 
altering T-bet or Eomes expression (Macintyre et al., 2011), suggesting T-box factor 
independent pathways for cytotoxic gene regulation. As a result, multiple transcription 
factors may compensate for lack of Eomes in activating cytotoxic genes in effector CD8+ 
T cells.  
We have recently reported a role for Eomes in the generation of central memory 
CD8+ T cells in response to viral infection (Banerjee et al., 2010). As the homologous T-
box factor T-bet drives the terminal differentiation of effector CD8+ T cells, one might 
hypothesize that Eomes would conversely drive formation of memory precursors. Eomes 
expression, however, did not correlate with markers of memory precursor cells, nor did 
deletion of Eomes impair the generation of memory precursors (Banerjee et al., 2010). 
Nevertheless, early Eomes expression was associated with more rapid accumulation of 
central memory CD8+ T cells. Therefore, Eomes likely supports memory differentiation 
after the stage of memory cell fate commitment. When Eomes begins to contribute to the 
program of memory differentiation, however, remains to be determined. 
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In CD8+ T cells expressing markers of long-lived, self-renewing central memory, 
Eomes protein expression was important for maintaining cells with stable expression of 
the Eomes locus. This failed persistence of CD8+ T cells that would normally express 
Eomes transcripts in the absence of Eomes protein appeared to be due to the impaired 
homeostatic proliferation.  Thus, Eomes- central memory CD8+ T cells may contain a 
distinct program for survival compared to Eomes+ central memory cells. 
We and others have reported the development of mature TRAIL-DX5+ NK cells 
from TRAIL+DX5- NK cells. However, the signals that initiate full maturation of 
TRAIL+DX5- precursors are unknown. Furthermore, the transcriptional events initiating 
the developmental program of NK maturation are similarly obscure. By examining 
Eomes-deficient NK cells carrying an Eomesgfp reporter allele, we were able to identify a 
small population of TRAIL+DX5- precursors that had activated Eomes transcription and 
potentially initiated subsequent steps in NK cell maturation. However, in the absence of 
Eomes protein, these GFP+TRAIL+ cells did not accumulate. Future studies will be 
needed to determine whether these cells fail to persist in the absence of Eomes protein 
as they progress through NK cell development or whether they return to the TRAIL+DX5- 
precursor program and repress Eomes expression. Further exploration of GFP+ 
TRAIL+DX5- precursors offers a novel opportunity to define the factors influencing NK 
cell maturation. 
Correlation of GFP protein with Eomes protein in Eomesgfp/+ mice revealed a 
population of NK and CD8+ T cells that express Eomes without GFP. The specificity, but 
incomplete sensitivity, of the inserted EGFP in the Eomes locus raises new potential 
insights into the regulation of Eomes expression in lymphocytes. One possibility is that 
the level of GFP protein needed for antibody or fluorescent detection is greater than the 
 
 
40 
level of Eomes protein required for equivalent detection. A second possibility, however, 
is that Eomes protein exhibits a longer half-life than that of EGFP. Thus, low 
transcriptional activity of the Eomes locus may lead to low levels of Eomes protein but 
undetectable levels of EGFP. This notion is consistent with the observation that small 
differences in Eomes mRNA (Intlekofer et al., 2005) can lead to large differences in 
Eomes protein (Banerjee et al., 2010). Investigations into the control of Eomes protein 
stability could allow for the potential to manipulate Eomes concentration in both healthy 
(Banerjee et al., 2010; Gordon et al., 2011; Gordon et al., 2012; Intlekofer et al., 2008; 
Intlekofer et al., 2005) and diseased states (Kinjyo et al., 2010). 
The ability to separate lymphocytes based on graded transcription factor 
expression is restricted to either the identification of correlative surface markers (Joshi et 
al., 2007) or the generation of reporter mice. This need is especially compelling in the 
case of transcription factors that exhibit a large dynamic range of expression within a 
single population. Thus, the generation of an Eomesgfp/+ reporter that exhibits robust 
fidelity to Eomes protein expression in cytotoxic lymphocytes should prove to be a 
beneficial tool in elucidating how heterogeneous Eomes expression results in differential 
fate or function.  
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CHAPTER 3: A critical role for balancing progenitor and terminal 
subsets of exhausted CD8+ T cells during chronic viral infection 
 
3.1 Introduction: 
Chronic viral infections, such as HIV, HBV, and HCV, contribute to substantial 
morbidity and mortality worldwide (Virgin et al., 2009). Defects in adaptive immune 
responses, such as CD8+ T cell exhaustion, limit complete viral control (Wherry, 2011). 
Exhausted CD8+ T cells do, however, provide some level of containment of these 
viruses. For example, depletion studies in SIV infected macaques or HCV infected 
chimpanzees demonstrate the central importance of T cells in these settings (Grakoui et 
al., 2003; Jin et al., 1999; Schmitz et al., 1999; Shoukry et al., 2003). Moreover, 
molecular escape from CD8+ (and CD4+) T cell responses during chronic viral infection 
demonstrates the important pressure that even exhausted CD8+ T cell place on chronic 
viral infections. However, these antiviral CD8+ T cells are under tremendous pressure 
and often receive strong, ongoing antigenic stimulation throughout the course of chronic 
infection. 
Previous examination of T cells during HIV infection revealed a dramatic increase 
in the level of CD8+ T cell proliferation and turnover during the chronic phase of infection 
(Hazenberg et al., 2000; Hellerstein et al., 1999; McCune et al., 2000; Sachsenberg et 
al., 1998). One contributing factor to this high rate of CD8+ T cell turnover may be the 
virus-specific CD8+ T cell response. Consistent with this hypothesis, in a murine model 
of chronic viral infection, virus-specific CD8+ T cells displayed extensive proliferation in 
vivo (Shin et al., 2007). The high rate of replication and cell turnover, however, may also 
lead to detrimental effects on the CD8+ T cell response. For example, HIV-infected 
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individuals with higher rates of T cell proliferation and corresponding immune activation 
have an accelerated rate of disease progression (Giorgi et al., 1999; Hazenberg et al., 
2000). Thus, how virus-specific CD8+ T cells might adapt during chronic infections to 
continuously repopulate the anti-viral CD8+ T cell pool over a prolonged period are 
unknown. 
After initial infection and effector expansion, CD8+ T cells undergo contraction 
both when the infection is rapidly cleared and when the pathogen persists. Following 
acute infections, memory CD8+ T cell populations form. These memory CD8+ T cells 
return to quiescence but acquire the ability to self-renew in an antigen-independent 
manner, utilizing IL-7 and IL-15 for their maintenance (Becker et al., 2002; Goldrath et 
al., 2002; Lau et al., 1994; Murali-Krishna et al., 1999; Tan et al., 2002; Wiehagen et al., 
2010). During chronic infection, however, antigen-independent memory CD8+ T cells 
often do not develop. Instead, a stable population of CD8+ T cells persists via a distinct, 
antigen-dependent type of maintenance that remains poorly understood. 
Over the lifespan of an organism, several tissues experience extensive cell 
turnover and repeatedly repopulate a terminally differentiated population. These tissues, 
such as the epithelium of the skin and gut, adapt to these demands by having a 
collection of long-lived precursor cells that give rise to a short-lived and terminally-
differentiated cell population. Often, this process is coupled to extensive division, 
allowing for a small population of progenitors to maintain the much larger population of 
cells that execute tissue-specific functions.  
In the case of chronic infection, where virus-specific CD8+ T cells experience the 
stress of constant antigenic stimulation, a similar phenomenon might occur. In this case, 
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a small population of cells would be dedicated to longevity of the CD8+ T cell response 
by preserving the unique TCR sequence that confers antigen specificity. This small 
population, however, would act as precursors and would repeatedly give rise to a much 
larger, more differentiated, anti-viral CD8+ T cell population. Whether this process occurs 
in virus-specific CD8+ T cells during a chronic infection is unclear. Furthermore, what 
transcription factors would govern this process is not known. 
Eomesodermin (Eomes) and T-bet are homologous T-box transcription factors 
(Pearce et al., 2003; Russ et al., 2000; Szabo et al., 2000) that are involved in a variety 
of developmental processes. Both transcription factors support the anti-viral CD8+ T cell 
response, in part through their activation of a number of genes encoding effector 
molecules, such as IFN-g, perforin, and gramzyme B (Intlekofer et al., 2008; Lewis et al., 
2007; Pearce et al., 2003; Szabo et al., 2000; Townsend et al., 2004). Consequently, 
expression of these factors has been associated heretofore with effective and functional 
CD8+ T cell responses.  
In some cases, however, two related T-box factors may promote alternative cell 
states along similar differentiation processes. For example, in acutely-resolved 
infections, T-bet directs CD8+ T cells to adopt a terminally-differentiated cell fate during 
the acute effector phase of the response (Intlekofer et al., 2007; Joshi et al., 2007), while 
Eomes supports the persistence of long-lived, self-renewing central memory CD8+ T 
cells long after the pathogen is cleared (Banerjee et al., 2010). Whether Eomes and T-
bet govern alternative cell states in CD8+ T cells during a chronic viral infection, 
however, is unknown. 
 
 
44 
Here we report that, unlike T-bet which is down-regulated during dysfunctional 
CD8+ T cell responses to a chronic viral infection (Kao et al., 2011), Eomes is strongly 
upregulated in virus-specific CD8+ T cells. In addition, Eomes expression correlates with 
features of severe exhaustion. Nevertheless, Eomes expression is essential for 
maintaining the maximal CD8+ T cell response to limit viral replication. Eomes and T-bet 
support the persistence of two distinct subsets during the CD8+ T cell response to a 
chronic viral infection. T-bethi Eomeslo CD8+ T cells exhibit low levels of proliferation and 
cell turnover in vivo; however these cells acts as progenitor cells that give rise to the T-
betlo Eomeshi population, a process that is coupled to extensive cell division. This 
amplified population then has a more limited ability to give rise to more progeny. Thus, 
Eomes and T-bet govern the balance between terminal differentiation and population 
renewal in CD8+ T cells during chronic viral infection. 
 
3.2 Methods: 
3.2.1 Human Subjects:  
All human subjects were recruited at the Massachusetts General Hospital 
Gastrointestinal Unit and the Department of Surgery in accordance with the IRB 
approved study: “Cell mediated immunity in Hepatitis C virus infection”; Protocol # 1999-
P-004983/54; MGH Legacy #: 90-7246. Liver specimens were obtained from 
explantation or resection of 8 patients with at least 5 years of chronic HCV infection, 
defined by positive anti-HCV antibody and detectable viral load. Three patients with 
treatment induced sustained virological response (SVR, undetectable viral load 6 
months after end of treatment) were analyzed. SVR of all 3 patients was achieved at 
least 3 years prior to liver sampling. Intrahepatic lymphocytes (IHL) were extracted by 
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mechanical disruption of liver tissue. The cell suspension was then washed twice in 
RPMI 1640 culture medium supplemented with 10% FBS, followed by centrifugation at 
300 rpm each time to remove cell debris and hepatocytes. The final washing step was 
followed by centrifugation at 1500 rpm to obtain a pellet of IHL.  
3.2.2 Mice and Infections: 
All animals were housed at the University of Pennsylvania (Philadelphia, PA). 
Experiments were performed in accordance with protocols approved by the University of 
Pennsylvania Institutional Animal Care and Use Committee. Eomesflox/flox, Eomesgfp/+, 
and Tbx21-/- (T-bet KO) mice have been described previously (Arnold et al., 2009; 
Finotto et al., 2002; Intlekofer et al., 2008). To examine CD8+ T cell differentiation in the 
absence of Eomes, Eomesflox/flox mice were crossed to CD4-Cre mice (Eomes cKO) 
(Intlekofer et al., 2008). CD4-Cre+ Eomes+/+ or littermate CD4-Cre- Eomesf/f mice were 
used as WT controls. Mice were infected with either 2 x 105 PFU of lymphocytic 
choriomenigitis virus (LCMV) Armstrong strain by i.p. injection to generate an acutely 
resolved infection or 4 x 106 PFU of LCMV clone 13 strain by i.v. injection to generate a 
chronic infection. The V35A variant of clone 13 has been previously described (Blattman 
et al., 2009; Shin et al., 2007).  
3.2.3 Flow cytometry and real-time PCR: 
Surface staining was performed as described previously (Gordon et al., 2011; 
Intlekofer et al., 2008). Intracellular staining was performed using the Foxp3 / 
Transcription Factor Staining Buffer Set per manufacturer’s instructions (eBioscience; 
San Diego, CA). Antibodies used for flow cytometry were purchased from BD 
Biosciences (CD4, CD8, CD19, CD44, 2B4, Ki-67; San Jose, CA), Biolegend (PD-1, 
Tim3, TNF-α, IFN-γ, T-bet; San Diego, CA), R&D Systems (MIP-1α; Minneapolis, MN), 
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or eBioscience (CD8, Lag3, CD160, 2B4, CD45.1, CD45.2, CD107a, Eomes). MHC 
class I peptide tetramers were made and used as described previously (Wherry et al., 
2004; Wherry et al., 2003a). Data were collected on a BD LSRII (BD Biosciences) and 
analyzed with FlowJo software (Tree Star, Ashland, OR). Cell sorting was performed 
using a BD Aria II (BD Biosciences). qRT-PCR was carried out as previously described 
(Gordon et al., 2012; Intlekofer et al., 2008). Gene expression was normalized to 
GAPDH. Target gene probes were purchased from Applied Biosystems (Foster City, 
CA). 
3.2.4 Bone Marrow Chimeras 
Bone marrow (BM) from WT (CD45.1+), T-bet KO (CD45.2+), and Eomes cKO 
(CD45.2+) donors was harvested. 5-10 x 106 donor cells were transferred i.v. into 
sublethally irradiated (450 rads) Rag2-/- recipients. 8 weeks after BM transfer, chimeras 
were infected with LCMV clone 13. 
3.2.5 BrdU Treatment and Detection 
Animals were treated with 2mg of BrdU (Sigma-Aldrich; St. Louis, MO) i.p. daily 
for 7 days prior to tissue harvest and analysis. BrdU incorporation was assessed by the 
BrdU Flow Kit per manufacturer’s instructions (BD Biosciences). 
3.2.6 CFSE labeling, temporal deletion and adoptive transfers: 
At indicated days p.i., spleens were harvested from indicated CD45.2+ donor 
mice. CD8+ T cells were purified from splenocytes using magnetic beads according to 
manufacturer’s protocol (CD8+ negative selection; MACS beads; Miltenyi Biotec, Auburn, 
CA). Purified CD8+ T cells were labeled with CFSE as described previously (Wherry et 
al., 2004; Wherry et al., 2003a), and transferred i.v. into CD45.1+ infection-matched 
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controls. Temporal Eomes deletion with Tat-Cre was performed as described (Gordon et 
al., 2012). 
3.2.7 Statistical Analysis: 
Student’s t test (Paired and Unpaired), Mann-Whitney test, and 2-way ANOVA 
were performed using Prism software (Graphpad, La Jolla, CA). 
 
3.3 Results: 
3.3.1 Eomes expression is enhanced during chronic viral infection. 
During chronic viral infections in humans and mice, T-bet expression is reduced 
in virus-specific CD8+ T cells and this reduction correlates with T cell dysfunction 
(Hersperger et al., 2011; Kao et al., 2011; Ribeiro-Dos-Santos et al., 2012). In contrast, 
microarray analysis of CD8+ T cells has suggested that Eomes mRNA is elevated during 
chronic infection (Wherry et al., 2007). We first validated these findings by RT-PCR in 
sorted virus-specific CD8+ T cells from an acutely resolved infection with lymphocytic 
choriomeningitis virus (LCMV) Armstrong (Arm) at day 8 (effector) and day 30 post-
infection (memory) or from a chronic infection with LCMV clone-13 (cl-13) at day 30 
post-infection (exhausted). Eomes expression was compared to naïve (CD44lo) CD8+ T 
cells from uninfected mice. Consistent with microarray analysis, Eomes expression was 
strongly upregulated during chronic infection (Fig 3.1A). We next determined whether 
the elevated levels of Eomes was due to an increase in the frequency of cells expressing 
Eomes or an increase in Eomes expression per cell. Infection of an Eomes GFP reporter 
mouse (Eomesgfp/+) (Arnold et al., 2009) with LCMV Arm generated a modest frequency 
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Figure 3.1. Eomes expression is enhanced during chronic viral infection. (A) Naïve 
or gp276-specific CD8+ T cells from effector (Arm d8), memory (Arm d30), or exhausted 
(cl-13 d30) time-points were sorted and analyzed for Eomes mRNA expression 
normalized to GAPDH. (B) Longitudinal histograms of GFP expression in gp33-specific 
CD8+ T cells from the blood of WT (shaded) or Eomesgfp/+ (open) mice at indicated days 
post Arm or cl-13 infection. (C) Eomes protein expression in gp33-specific CD8+ T cells 
from the spleens of WT mice 8, 15, or 30 days post-infection with Arm or cl-13. (B-C) 
Numbers indicate frequencies of gated populations. (D) MFI of Eomes expression from 
cells in (C). 
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 of GFP+ virus-specific CD8+ T cells (Fig 3.1B). In contrast, infection of Eomesgfp/+ mice 
with LCMV cl-13 resulted in a robust frequency of GFP+ virus-specific CD8+ T cells (Fig 
3.1B). Thus, the enhanced Eomes expression results – at least in part – from an 
increase in the frequency of cells expressing Eomes mRNA. 
We next validated that the enhanced Eomes mRNA expression resulted in 
increased Eomes protein. Isolation of virus-specific CD8+ T cells from LCMV Arm or cl-
13 infected mice revealed high levels of Eomes protein expression at the peak of the 
CD8+ T cell response (day 8 post-infection). Clearance of viral antigen during acute 
infection led to an initial drop in Eomes expression at day 15 that subsequently 
increased as the population began to mature into central memory (day 30). In contrast, 
high levels of Eomes protein expression persisted during chronic viral infection (Fig 
3.1C,D). Thus, Eomes expression is highly upregulated in virus-specific CD8+ T cells 
during chronic viral infection. 
3.3.2 Eomes expression correlates with features of CD8+ T cell exhaustion. 
As CD8+ T cells during chronic viral infections exhibit heterogeneity in surface 
phenotype, transcriptional profile, and function, we examined how Eomes expression 
correlated with known features of CD8+ T cell exhaustion. We first investigated whether 
Eomes expression was correlated with the expression of inhibitory receptors, which have 
been demonstrated to impair optimal CD8+ T cell function during chronic viral infection 
(Barber et al., 2006; Blackburn et al., 2010; Blackburn et al., 2009; Wherry, 2011). 
Examination of virus-specific CD8+ T cells 30 days post-infection with LCMV cl-13 
revealed a positive correlation between the expression of Eomes and several inhibitory 
receptors (PD-1, Lag3, CD160, & Tim3) (Fig 3.2A).  
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As Eomes appeared to correlate with markers of dysfunction (Blackburn et al., 
2009), we next determined how Eomes expression related to other transcription factors 
that regulate CD8+ T cell responses during chronic viral infection. In particular, based on 
the positive correlation between Eomes and inhibitory receptor expression, we predicted 
a negative correlation between T-bet and Eomes (Kao et al., 2011) and a positive 
correlation between Eomes and Blimp1 (Shin et al., 2009).  
After an acute infection with LCMV Arm, Eomes did not strongly correlate – 
positively or negatively – with the expression of T-bet (Fig 3.2B; top row). In contrast, 
virus-specific CD8+ T cells from chronically infected mice developed a prominent inverse 
correlation in the expression of T-bet and Eomes (Fig 3.2B; bottom row). In order to 
evaluate Blimp1 and Eomes co-expression, we crossed Blimp1 YFP reporter mice 
(Rutishauser et al., 2009; Shin et al., 2009) to Eomesgfp/+ mice. Dual reporter mice 
revealed a modest frequency of YFP and GFP co-expression at the peak of the CD8+ T 
cell response 8 days post-infection with LCMV Arm. This co-expression gradually 
declined as the cell-population matured towards central memory (Fig 3.2C; top row). 
Similar to acute infection, CD8+ T cells displayed a low frequency of YFP and GFP co-
expression 8 days after LCMV cl-13 infection. However, chronic viral infection lead to a 
substantial frequency of co-expression of YFP and GFP that persisted for at least two 
months post-infection (Fig 3.2C; bottom row). Thus during chronic viral infection, 
Eomes expression correlates with CD8+ T cells that exhibit phenotypic and 
transcriptional characteristics of CD8+ T cell exhaustion. 
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Figure 3.2. Eomes expression correlates with phenotypic and transcriptional 
features of CD8+ T cell exhaustion. (A) Eomes positively correlates with inhibitory 
receptor expression. Plots display indicated inhibitory receptor expression versus Eomes 
expression in gp33-specific CD8+ T cells 30 days post-infection. (B) T-bet and Eomes 
inversely correlate in virus-specific CD8+ T cells during chronic infection. T-bet versus 
Eomes expression in gp33-specifc CD8+ T cells 8, 15, or 30 days post-infection with Arm 
or cl-13. Gates are based on naïve cells from uninfected mice. (C) Blimp1 and Eomes 
co-expression is enriched during chronic infection. Longitudinal frequency of GFP+YFP+ 
gp33-specific CD8+ T cells in the blood of Blimp1-YFP/Eomesgfp/+ dual reporter mice 
after Arm or cl-13 infection. Gates are based on WT and single reporter mice. Numbers 
denote frequency of gated population. 
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Figure 3.3. Eomes expression correlates with functional features of CD8+ T cell 
exhaustion. (A) Eomes expression correlates with increased granzyme B expression. 
Histograms of granzyme B expression in naïve (gray) or Eomes+ and Eomes- gp276-
specifc CD8+ T cells (open) 22 days post-infection. (B) Eomes expression correlates with 
reduced degranulation. Histograms of CD107a staining of naïve (gray) or Eomes+ and 
Eomes- MIP-1α+ CD8+ T cells (open) after stimulation with gp276-286 peptide on day 23 
post-infection. (C) Eomes expression correlates with reduced co-expression of IFN-γ and 
TNF-α. 22 days post-infection, CD8+ T cells were stimulated with gp33-41, gp276-286, 
or a LCMV peptide pool and expression of IFN-γ and TNF-α was assessed for Eomes+ 
and Eomes- CD8+ T cells. Numbers denote frequency of gated population. 
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We therefore examined how Eomes expression was associated with functional 
changes associated with CD8+ T cell exhaustion. We have previously reported an 
inverse correlation between inhibitory receptor expression and CD8+ T cell function 
during chronic infection (Blackburn et al., 2010; Blackburn et al., 2009). The impaired 
cytotoxicity is associated with reduced degranulation as measured by CD107a staining, 
yet paradoxically increased staining for granzyme B (Blackburn et al., 2010). Consistent 
with the positive correlation between Eomes and PD-1, granzyme B expression was 
enhanced in Eomes-expressing CD8+ T cells (Fig 3.3A), whereas CD107a staining was 
reduced (Fig 3.3B).  
We have also reported that the expression of multiple inhibitory receptors 
inversely correlates with cytokine expression, in particular co-expression of IFN-γ and 
TNF-α (Blackburn et al., 2009). Therefore, we investigated whether Eomes expression 
correlated with differential cytokine expression. Examination of Eomes+ and Eomes- 
CD8+ T cells that express MIP-1α or stain for CD107a after peptide stimulation revealed 
equivalent frequencies of IFN-γ expression. In contrast, the ability to co-express IFN-γ 
with TNF-α was reduced in Eomes+ CD8+ T cells compared to Eomes- CD8+ T cells (Fig 
3.3C). Thus, Eomes expression is elevated in virus-specific CD8+ T cells that 
phenotypically, transcriptionally, and functionally display features of terminal exhaustion. 
3.3.3 Deletion of Eomes leads to reduced features of CD8+ T cell exhaustion. 
While WT CD8+ T cells had bimodal expression of T-bet and Eomes, genetic 
deletion of T-bet resulted in an increase in Eomes and PD-1 expression (Fig 3.4A), 
consistent with enhanced exhaustion (Kao et al., 2011). In contrast, Eomes-deficient 
CD8+ T cells had reduced PD-1 and Blimp1, as well as increased T-bet and functionality 
(Fig 3.4B,C).  
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Figure 3.4. Eomes deficient CD8+ T cells appear less exhausted. (A) T-bet, Eomes, 
and PD-1 expression of Dbgp33-specific CD8+ T cells from WT, T-bet KO, and Eomes 
cKO mice on d22 p.i. Numbers denote frequency of gated population. (B) Blimp1 relative 
mRNA in Dbgp276-specific CD8+ T cells from WT and Eomes cKO mice on d15 p.i. 
(*p<0.05; Mann Whitney) (C) CD8+ T cells from WT and EKO mice were assessed for 
IFN-γ and TNF-α expression after peptide pool stimulation as in Fig 3.3 on d22 p.i. 
(**p<0.01; Unpaired t test).  
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Figure 3.5. Eomes acts cell-intrinsically to maintain the more exhausted CD8+ T 
cell population. Rag KO hosts were sublethally irradiated and reconstituted with a 1:1 
mixture of WT and Eomes cKO bone marrow, followed by infection with LCMV clone 13. 
(A) T-bet and PD-1 expression in Dbgp276-specific CD8+ T cells d60 p.i. Numbers 
denote frequency of gated population. (B) MFI of T-bet and PD-1 expression from cells 
in (A). (*p<0.05, **p<0.01; Paired t test) 
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These features of reduced exhaustion in Eomes-deficient CD8+ T cells were 
determined to be cell-intrinsic through the use of mixed bone-marrow chimeras (Fig 3.5). 
Thus, T-bet and Eomes support separate subpopulations of virus-specific CD8+ T cells 
during chronic viral infection. 
3.3.4 T-bet and Eomes regulate distinct proliferative properties. 
Previous studies in mice and humans suggest that proliferating and non-proliferating 
subpopulations of exhausted CD8+ T cells might exist during chronic infections 
(Hellerstein et al., 2003; Shin et al., 2007), but the regulation of this process is poorly 
understood. We hypothesized that T-bethi and Eomeshi CD8+ T cells might have different 
in vivo proliferative dynamics. While T-bethi CD8+ T cells had low Ki-67 expression and 
BrdU incorporation, Eomeshi CD8+ T cells expressed Ki-67 and incorporated BrdU at 
high frequencies in multiple anatomical sites, including the liver (Fig 3.6A-C). Using 
CFSE labeling to trace division history and associated changes in differentiation in vivo, 
we observed robust proliferation in Eomeshi CD8+ T cells, while less CFSE dilution was 
found in the T-bethi population (Fig 3.6D). The modest proliferation of T-bethi cells was 
unlikely the result of limited access to antigen, since essentially all virus-specific memory 
CD8+ T cells divided extensively when transferred into chronically infected mice (Fig 
3.7). In addition, T-bet and Eomes governed these distinct proliferative behaviors since 
deletion of T-bet increased CD8+ T cell Ki-67 expression and BrdU incorporation, while 
loss of Eomes diminished cell proliferation (Fig 3.8, 3.9). Thus, T-bet and Eomes 
regulate distinct CD8+ T cell pools with differential division during chronic infection. 
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Figure 3.6. T-bet and Eomes subsets exhibit differential proliferation. (A) Ki-67 
expression is increased in T-betlo Eomeshi virus-specific CD8+ T cells. Flow cytometry of 
T-bet, Eomes, and PD-1 expression versus Ki-67 expression in gp33-specific CD8+ T 
cells 22 days post-infection. (B) BrdU incorporation is increased in T-betlo Eomeshi virus-
specific CD8+ T cells. Infected WT mice were injected with 2mg of BrdU daily from day 
15 to day 21 post-infection. Flow cytometry of T-bet, Eomes, and PD-1 expression 
versus BrdU incorporation in gp33-specific CD8+ T cells 22 days post-infection. (C) BrdU 
incorporation occurs predominantly in the T-betlo Eomeshi subset of virus-specific CD8+ T 
cells in multiple tissues. Infected mice were treated with BrdU as in (B). Plots display 
Eomes expression versus BrdU incorporation in gp276-specific CD8+ T cells from 
indicated organs. (D) Extensive proliferation is associated with Eomes expression. CD8+ 
T cells from CD45.2 infected mice were isolated 15 days post-infection, CFSE-labeled, 
and transferred into infection-matched CD45.1 hosts. One week post-transfer, virus-
specific CD8+ T cells were analyzed for CFSE dilution. Plots show T-bet, Eomes, and 
PD-1 expression versus CFSE dilution in gp276-specific donor CD8+ T cells. Numbers 
indicate frequencies of gated populations. 
 
 
59 
 
 
Figure 3.7. Lack of division in exhausted CD8+ T cells is not due to lack of 
proliferative (antigenic) stimuli. (A) CD8+ T cells from CD45.2 LCMV Armstrong-
immune (d30+) or clone 13 chronically infected (d30) mice were isolated, CFSE-labeled, 
and transferred into LCMV Armstrong-immune (d30+) or chronically infected (d30) 
CD45.1 recipient mice. One week post-transfer, virus-specific CD8+ T cells were 
analyzed for CFSE dilution. (B) Plots show CFSE dilution in Dbgp33-specific donor CD8+ 
T cells. 
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Figure 3.8. Deletion of either T-bet or Eomes leads to opposite effects on 
proliferation. Ki-67 expression in gp33-specific CD8+ T cells from WT, T-bet KO, and 
Eomes cKO mice at indicated days post-infection. 
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Figure 3.9. T-bet deficient CD8+ T cells exhibit enhanced proliferation, whereas 
Eomes deficient CD8+ T cells display reduced proliferation. BrdU incorporation in 
gp276-specific CD8+ T cells from WT, T-bet KO, and Eomes cKO mice. Mice were 
treated with BrdU and analyzed as in Fig 3.6. 
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3.3.5 T-bethi progenitors give rise to Eomeshi progeny. 
To trace lineage relationships between these subpopulations of exhausted CD8+ 
T cells, we first used expression of PD-1 as a surrogate surface marker of T-bethi and 
Eomeshi subsets together with CFSE labeling to monitor proliferation and differentiation 
in vivo (Fig 3.10A,B). Following adoptive transfer to infection-matched mice, PD-1hi (T-
betlo Eomeshi) CD8+ T cells divided modestly and retained high expression of PD-1 (Fig 
3.10C). In contrast, PD-1int (T-bethi Eomeslo) CD8+ T cells demonstrated enhanced in 
vivo proliferation and this extensive division was associated with conversion to PD-1hi 
(Fig 3.10C). Similar results were obtained using the Eomesgfp/+ reporter mouse (Fig 
3.11A). Two weeks post-transfer, GFP+ CD8+ T cells maintained GFP expression while 
some GFP- transitioned to GFP+ (Fig 3.11B). Thus, virus-specific CD8+ T cells appear to 
convert from T-bethi to Eomeshi in a process coupled to extensive cell division. Once 
generated, however, the PD-1hiEomeshiT-betlo subset had a reduced capacity to undergo 
additional proliferation in vivo. To test whether Eomes was essential during the T-bethi to 
Eomeshi transition, virus-specific CD8+ T cells from chronically infected Eomes+/+ and 
Eomesf/f mice were treated in vitro with Tat-Cre and adoptively transferred into infection-
matched mice (Fig 3.12A). The temporal loss of Eomes led to a reduction in the 
extensively divided CD8+ T cell population (Fig 3.12B), suggesting that Eomes plays a 
critical role in initiating or sustaining this proliferative event. 
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Figure 3.10. T-bethi Eomeslo CD8+ T cells convert to T-betlo Eomeshi CD8+ T cells. 
PD-1int CD8+ T cells convert to PD-1hi CD8+ T cells during extensive proliferation. (A) 
Relative expression of T-bet, Eomes, and PD-1 in Dbgp33-specific CD8+ T cells d21 post 
clone 13 infection. (B) CD8+ T cells from chronically infected CD45.2 mice were isolated 
d22 p.i., sorted based on PD-1 expression, CFSE-labeled, and transferred into infection-
matched CD45.1 recipient mice. PD-1 expression and CFSE dilution were assessed 7 
days post-transfer. (C) Plots display PD-1 expression versus CFSE dilution of donor 
gp276-specific CD8+ T cells. Numbers indicate frequencies of gated populations. 
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Figure 3.11. T-bethi Eomeslo CD8+ T cells convert to T-betlo Eomeshi CD8+ T cells. 
GFP- CD8+ T cells from Eomesgfp/+ mice convert to GFP+ CD8+ T cells. (A) CD8+ T cells 
from chronically infected Eomesgfp/+ mice were isolated d15 p.i., sorted based on GFP 
expression, and transferred into infection-matched CD45.1 recipient mice. (B) Plots 
display GFP expression (open) in donor gp276-specific CD8+ T cells 2 weeks post-
transfer. Numbers indicate frequencies of gated populations. 
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Figure 3.12. Eomes regulates the initiation or continuation of extensive CD8+ T cell 
proliferation. (A) CD8+ T cells from chronically infected Eomes+/+ or Eomesf/f mice were 
isolated d15 p.i., treated with Tat-Cre in vitro, CFSE-labeled, and transferred into 
infection-matched CD45.1 recipient mice. Two weeks post-transfer, virus-specific CD8+ 
T cells were analyzed for CFSE dilution. (B) Plots display Eomes and PD-1 expression 
and CFSE dilution in donor gp276-specific CD8+ T cells. Numbers indicate frequencies 
of gated populations. 
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3.3.6 Loss of T-bet or Eomes leads to loss of the CD8+ T cell response and impaired 
viral control. 
The absence of T-bet impedes the control of chronic viral infection, presumably 
due to a shift towards more exhausted CD8+ T cells (Kao et al., 2011). In light of the 
reduced features of exhaustion when Eomes was deleted (Fig 3.4, 3.5), we tested 
whether eliminating Eomes would improve control of chronic viral infection. In the 
absence of T-bet or Eomes, however, virus-specific CD8+ T cells could neither maintain 
the antiviral response (Fig 3.13A, B) nor limit viral replication (Fig 3.13C, D). Since each 
subpopulation failed to independently sustain an effective antiviral response, it was 
possible that the T-bet- and Eomes-dependent subsets might contribute distinct 
functions and cooperate to achieve viral control. To test this possibility, mixed chimeras 
containing both Eomes cKO and T-bet KO bone marrow together were examined. 
Combination of Eomes cKO (T-bethi) and T-bet KO (Eomeshi) exhausted CD8+ T cells, 
however, did not improve viral control over either subset alone (Fig 3.13E). These data 
suggest that the major factor sustaining virus-specific CD8+ T cell responses and limiting 
viral replication during chronic infection is not independent functional attributes of T-bethi 
and Eomeshi CD8+ T cells, but rather the lineage relationship between these 
subpopulations. 
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Figure 3.13. Deletion of T-bet or Eomes leads to impaired maintenance of the CD8+ 
T cell response and loss of viral control. (A) Longitudinal frequency of gp33-specific 
CD8+ T cells in the blood of infected mice. (B) Total gp276-specific CD8+ T cells in the 
spleens of infected mice at d30 p.i. (*p<0.05; Unpaired t test) (C) Longitudinal viral load 
in the serum of infected mice. (D) Viral load in the kidney at d90 p.i. (E) Viral load in 
kidneys of bone marrow (BM) chimeras transplanted with WT, TKO, EKO, or TKO and 
EKO BM at d90 p.i. (*p<0.05, **p<0.01; Mann Whitney) 
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3.3.7 Antigen drives the differentiation from T-bethi precursors to Eomeshi progeny. 
Persisting antigen appears to be essential for converting T-bethi precursors into 
the more terminal Eomeshi progeny. Compared to cells adoptively transferred into a WT 
infection, transfer into mice chronically infected a variant of LCMV containing an epitope-
destroying mutation at position 35 (V35A) in the gp33-41 epitope (Shin et al., 2007) 
selected for Dbgp33-specific CD8+ T cells with elevated T-bet but reduced Eomes and 
PD-1 expression (Fig 3.14A). If persisting antigen induces T-bethi precursors to 
continually give rise to highly proliferated Eomeshi progeny, one might predict that 
prolonged, uncontrolled viral replication could lead to an eventual depletion of the T-
bethiEomeslo precursor population. To test this possibility, CD4+ T cells were transiently 
depleted during LCMV clone 13 infection, a treatment that leads to lifelong high viral load 
(Matloubian et al., 1994). Sustained high viral loads caused an erosion of the in vivo 
proliferation of the Eomeshi subset and loss of T-bethi precursors over time (Fig 3.14B-
D), suggesting a progressive imbalance of T-bethi to Eomeshi lineage repopulation. 
3.3.8 Antigen drives the differentiation of T-bethi precursors to Eomeshi progeny during 
hepatitis C infection. 
To examine whether years of chronic viral infection strain CD8+ T cell renewal by 
continuous depletion of the T-bethi Eomeslo precursor pool, we examined human 
subjects infected with hepatitis C virus (HCV). While 20-30% of HCV infections 
spontaneously resolve, most untreated patients experience a high viral burden for many 
years (Micallef et al., 2006). Over time, patients with uncontrolled viral replication have a 
gradual loss of systemic CD8+ T cell responses with an associated accumulation of 
highly exhausted T cells in the liver (Kasprowicz et al., 2008; Lechner et al., 2000; 
McMahan et al., 2010; Nakamoto et al., 2008), consistent with a dysregulated balance 
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between self-renewal and terminal differentiation. We therefore examined whether T-
bethi Eomeslo precursors could be found in patients with resolved versus chronic HCV 
infection and whether T-betlo Eomeshi progeny accumulated in patients with active viral 
replication (Fig 3.15A). While HCV-specific CD8+ T cells in the blood displayed a trend 
toward higher Eomes expression in chronically infected subjects, there was equivalent 
T-bet expression in systemic responses from resolved or chronic infection (Fig 3.15B). 
In contrast, at the site of viral replication, there was substantial accrual of Eomeshi HCV-
specific CD8+ T cells and a relative depletion of the T-bethi subset during chronic 
infection compared to resolved infection (Fig 3.15B). Consistent with the observations in 
mice, chronic HCV infection is associated with few T-bethi precursors and a concurrent 
accumulation of Eomeshi terminal progeny. 
 
 
70 
 
Figure 3.14. Persistent antigen may progressively deplete the T-bethi Eomeslo CD8+ 
T precursor pool. (A) CD8+ T cells from infected mice were isolated at d8 p.i. and 
transferred to mice infected with either WT (shaded) or V35A (open) clone 13. Plots 
display T-bet, Eomes, and PD-1 expression in Dbgp33-specific CD8+ T cells in the 
presence (shaded) or absence (open) of antigen. (B) Eomes and PD-1 expression 
versus BrdU incorporation in Dbgp276-specific CD8+ T cells from WT mice infected with 
clone 13 with or without CD4 depletion. (C) Quantification of BrdU incorporation in (B). 
(D) Total T-bethi gp33-specific CD8+ T cells were assessed at indicated time-points in the 
spleens of chronically infected WT mice with or without CD4+ T cell depletion. 
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Figure 3.15. Antigen drives the differentiation of T-bethi precursors to Eomeshi 
progeny during hepatitis C infection. (A) T-bet, Eomes, and PD-1 expression in 
intrahepatic HCV-specific CD8+ T cells for resolved and chronic infections. (B) 
Frequency of Eomeshi and T-bethi HCV-specific CD8+ T cells in the blood and liver of 
resolved and chronic infections. 
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3.4 Discussion: 
Memory CD8+ T cells generated after acutely resolved infection or successful 
vaccination are quiescent, but capable of self-renewal and production of differentiated 
effector progeny upon re-infection (Ciocca et al., 2012; Wherry et al., 2003b). In contrast, 
exhausted CD8+ T cells during chronic infections are continually activated by persisting 
antigen and undergo prolonged, extensive division (Casazza et al., 2001; Shin et al., 
2007; Wherry et al., 2004). How the regenerative capacity of these cells develops and 
why it ultimately fails in pathological chronic infections has been unclear. Collectively, 
these studies suggest that, in the face of persisting antigen, virus-specific CD8+ T cells 
employ two homologous T-box transcription factors to maintain long-lasting antiviral 
immunity. This maintenance parallels progenitor-progeny dynamics of cells in other 
tissues organized according to proliferative hierarchies. In virus-specific CD8+ T cells, T-
bet preserves the less exhausted T-bethi Eomeslo precursor population that undergoes 
low rates of proliferation. In contrast, Eomes supports the more terminally exhausted T-
betlo Eomeshi population that has experienced extensive division, but has lost further 
proliferative potential. While unable to fully eradicate the virus, these two cell subsets act 
together to maintain a durable and partially effective CD8+ T cell response during chronic 
infection. 
Other extracellular signals have also been reported to be essential for 
maintenance of antiviral CD8+ T cell responses during chronic infection. For example, IL-
21 helps to preserve CD8+ T cell responses during chronic infection, presumably as one 
component of CD4+ T cell help (Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al., 
2009). Loss of IL-21 receptor signaling leads to a gradual loss of antiviral CD8+ T cell 
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responses (Elsaesser et al., 2009; Frohlich et al., 2009; Yi et al., 2009), however 
whether this is a uniform loss of the total population or a preferential loss of either the T-
bethi or Eomeshi sub-populations is not known. It is possible that IL-21 is an essential 
survival cytokine to sustain either the T-bethi or Eomeshi pools. Alternatively, IL-21 could 
provide an important signal to enhance the proliferation of the transit amplifying cell that 
will repopulate the Eomeshi pool. Although this question has not been fully explored, 
reduced BrdU incorporation and PD-1 expression early post infection in IL-21R KO cells 
from WT and IL-21R KO mixed bone marrow chimeras suggests that the Eomeshi 
population may be preferentially lost without IL-21 signaling (Frohlich et al., 2009). This 
suggests that IL-21 may provide proliferative signals to the transit amplifying cell or 
survival signals to the terminal Eomeshi population. This avenue of investigation could 
prove fruitful in understanding how extracellular cues help maintain antiviral CD8+ T cell 
responses, in particular if IL-21 is an important mechanism of CD4+ T cell help. 
Despite functional impairment, exhausted CD8+ T cells are not inert. Rather, 
these cells continually constrain viral replication and/or drive viral epitope escape 
(Wherry, 2011). Design of interventions that would enhance CD8+ T cell responses to 
chronic viral infections or malignancy is limited by an incomplete understanding of CD8+ 
T cell population dynamics. Such treatments could augment the virus-specific population 
by either (1) expanding the T-bethi precursor population, (2) improving the expansion 
properties of the transient amplifying population converting from a T-bethi to an Eomeshi 
state, or (3) protecting the terminally exhausted Eomeshi population from cell death. 
Several therapies, however, have already been observed to expand the anti-viral CD8+ T 
cell population (Barber et al., 2006; Brooks et al., 2006; Ejrnaes et al., 2006; Pellegrini et 
 
 
74 
al., 2011). The most prominent of these is blockade of inhibitory receptor pathways, in 
particular the PD-1 pathway (Wherry, 2011).  
While one might predict blockade of the PD-1 pathway would increase CD8+ T 
cell numbers by rescuing terminally exhausted CD8+ T cells, recent evidence instead 
suggests that PD-1 blockade preferentially affects either the T-bethi precursor population 
or a cell arising thereof. Examination of the effects of PD-1 blockade on exhausted CD8+ 
T cells separated by PD-1 expression demonstrated that PD-1 blockade has little to no 
impact on the properties of pre-formed PD-1hi (Eomeshi) progeny, but dramatically 
improves the ability of PD-1int (T-bethi) precursors to expand and exert anti-pathogen 
activities (Blackburn et al., 2008). The benefits of PD-1 blockade could act directly on T-
bethi cells and expand the precursor population, leading to a greater generation of 
Eomeshi progeny. Alternatively, PD-1 blockade may act to augment the amplification 
phase as T-bethi progenitors expand and differentiate into Eomeshi progeny. Determining 
which of these two processes may be the dominant effect of PD-1 blockade would 
suggest whether a short course of treatment would lead to a lasting effect on the CD8+ T 
cell response by permanently augmenting the progenitor population or only transiently 
boost the generation of antiviral progeny during the treatment period. 
Several investigators have also begun to observe opportunities in manipulating 
multiple inhibitory and costimulatory pathways simultaneously (Blackburn et al., 2009; 
Butler et al., 2011; Jin et al., 2010; Matsuzaki et al., 2010; McMahan et al., 2010; 
Nakamoto et al., 2009; Raziorrouh et al., 2010; Sakuishi et al., 2010; Vezys et al., 2011; 
Woo et al., 2011; Zhou et al., 2011). However, not all interventions lead to a lasting 
improvement of the CD8+ T cell response. For example, coupling of PD-1 blockade to 
strong 41BB co-stimulation led to a dramatic, yet transient, augmentation of the CD8+ T 
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cell response (Vezys et al., 2011). The large CD8+ T cell contraction after therapy could 
be due to a temporary loss of the transient amplifying population. Alternatively, the 
strong 41BB stimulus may have led to depletion of the T-bethi precursor population. This 
depletion would likely have detrimental consequences with regard to long-term viral 
control. Thus, while manipulation of inhibitory and costimulatory pathways may 
effectively expand the anti-viral CD8+ T cell population, care may be required to avoid 
unbalancing this dynamic process.  
A second question is how the T-bethi precursor population remains dormant 
despite the abundance of antigen present during a chronic viral infection.  One possibility 
is that T-bethi precursors occupy specialized antigen-poor sites, preventing antigen-
driven activation, proliferation, and differentiation. Alternatively T-bethi precursors may 
cell-intrinsically reduce T cell receptor signaling, entering a state of antigen ignorance. In 
either case, lack of antigen-driven activation may be an essential component to 
maintaining the T-bethi precursor population. 
Consistent with this hypothesis and in contrast to exhausted CD8+ T cells, 
memory CD8+ T cells extensively proliferate when transferred into a chronic viral 
infection and do not appear to preserve an undivided precursor population. Furthermore, 
recent work has demonstrated that a small population of memory CD8+ T cells is unable 
to sustain a prolonged anti-viral response (West et al., 2011). Thus, if present in 
sufficient quantities memory CD8+ T cells are effectively programmed to protect the host 
in the acute phase of challenge; however, if the viral challenge cannot be contained and 
establishes a chronic infection, memory CD8+ T cells may not contain the optimal 
transcriptional programming to adapt to high levels of persistent antigen. 
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The inability of memory CD8+ T cells to sustain an anti-viral response to a 
chronic infection may have implications for vaccine development. Vaccines have 
historically achieved efficacy through preventing productive infections. However, chronic 
viral infections such as HIV and HCV have eluded such vaccine strategies. Moreover, as 
noted above, failure to limit viral replication may lead to loss of a vaccine-induced CD8+ 
T cell population, rendering the host in a worse state than unvaccinated individuals. 
Recent investigations, however, may have provided an alternative vaccine strategy. 
Using a CMV-based vector for SIV vaccination, Hansen and colleagues elicited immune 
responses that did not prevent SIV infection, but instead quickly limited viral replication 
(Hansen et al., 2011). While SIV was not immediately eliminated, brief spikes in serum 
viral load occurred with reduced frequency over time, suggesting a prolonged and active 
CD8+ T cell response that progressively controlled viral replication. Many differences 
exist between the CMV-based platform and more common prime-boost regimes. 
However, delivery of persistent antigen by the CMV-based vector may induce the 
formation of a T-bethi CD8+ T cell precursor pool that resists antigen-induced activation 
and proliferation, allowing CD8+ T cells to generate a sustained and effective anti-viral 
response. Thus, in addition to strategies that may elicit sterilizing immunity, vaccine 
platforms that employ persistent antigen may offer a second approach to combat chronic 
viral infections. 
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CHAPTER 4: Concluding remarks and future directions 
 
4.1 Overview of Results. 
Eomes has been reported to direct the differentiation of NK (Gordon et al., 2012) 
and CD8+ T cells (Banerjee et al., 2010; Intlekofer et al., 2008; Intlekofer et al., 2005). 
What have remained less clear, however, are the specific features of the CD8+ T cell 
response that correlate with Eomes expression. In Chapter 2 of this thesis, Eomes 
expression was not associated with a differential cytotoxic potential of in vivo generated 
effector cells. Nevertheless, Eomes expression was associated with enhanced basal 
homeostatic proliferation and Eomes protein was essential to maintain this homeostatic 
division, a finding previously suggested (Banerjee et al., 2010; Intlekofer et al., 2005) but 
which had yet to be formally demonstrated. Thus, the description and characterization of 
the Eomesgfp/+ mouse has provided a solid foundation for exploration into the biology of 
Eomesodermin in both Chapters 2 & 3. This reagent may still provide opportunities to 
further discovery (discussed below). 
In CD8+ T cell responses to acutely resolved infections, Eomes supports the 
long-lived, self-renewing memory population. In contrast, during the course of a chronic 
viral infection, Eomes was found in Chapter 3 to support the generation and 
maintenance of a population of short-lived, terminally differentiated cells. Eomes helps to 
maintain this antiviral population by supporting the extensive cell division necessary to 
repeatedly repopulate this terminal pool from T-bethi precursors. Thus, depending on the 
duration of infection, T-box transcription factors appear to support either a long-lived 
progenitor pool or a terminally differentiated antiviral population. 
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The critical balance between progenitors and progeny in exhausted CD8+ T cells 
indicates a vital role for proper regulation of antiviral lymphocyte dynamics during 
chronic infections. The ability to define and monitor progenitors and progeny over time 
might provide an opportunity to predict the collapse of long-term control of chronic 
infections. Finally, delineating the molecular coordination of this process provides a 
framework for prophylactic or therapeutic strategies to improve the durability and 
regenerative capacity of antiviral T cells during persisting infections. 
4.2 Distinct or identical activity of T-box factors in response to acutely resolved vs 
chronic viral infection. 
Previous work has associated Eomes transcriptional activity with highly functional 
CD8+ T cell responses, either through the acquisition of effector functions (Intlekofer et 
al., 2008; Pearce et al., 2003) or through maintaining the long-lived and self-renewing 
central memory CD8+ T cell population after an acutely resolved infection (Banerjee et 
al., 2010; Intlekofer et al., 2005). Alternatively, T-bet activity is often associated with 
terminal differentiation (Intlekofer et al., 2007; Joshi et al., 2007). Thus, the findings in 
Chapter 3 that Eomes is highly expressed in more terminally differentiated and 
dysfunctional CD8+ T cells during chronic infection, while T-bet supports a less-
differentiated precursor population, may appear paradoxical. One possibility is that 
distinct cofactors arise in acute versus chronic infections and differentially modulate the 
transcriptional activity of T-box factors. Consistent with this hypothesis, Bcl6 appears to 
convert T-bet from a transcriptional activator to a repressor, at least for a select set of 
target genes (Oestreich et al., 2011). The pathways and functions that these T-box 
factors activate or repress may display a large degree of context-dependent variation. 
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An alternate or complimentary hypothesis, however, is that Eomes may regulate 
a common pathway that is shared across multiple cell types and environmental stimuli. 
During embryonic development, Eomes regulates both trophoblast formation (Russ et 
al., 2000) and neuronal development (Arnold et al., 2008). In the immune system, 
Eomes appears to regulate the maturation of NK cells (Gordon et al., 2012), self-
renewing central memory CD8+ T cells (Banerjee et al., 2010), and aberrant double-
negative T cells in the setting of autoimmune Autoimmune Lymphoproliferative 
Syndrome (ALPS) (Kinjyo et al., 2010).  One consistent feature in these disparate 
settings is that Eomes is expressed in cells undergoing proliferation. Furthermore, 
deletion of Eomes leads to the loss of this proliferative population (Arnold et al., 2008; 
Banerjee et al., 2010; Gordon et al., 2012; Kinjyo et al., 2010; Russ et al., 2000). Thus, 
Eomes may activate specific pathways – DNA damage responses, metabolic changes, 
etc. – that are essential for maintaining cells during these periods of proliferation. 
Understanding how Eomes might regulate cell proliferation may lead to novel or 
improved therapies directed at eliminating unwanted populations such as in ALPS or 
bolstering desired populations such as in anti-viral or anti-tumor CD8+ T cell responses. 
4.3 Use of a fluorescent reporter to identify transcriptional targets and regulators 
of Eomesodermin.  
Identification of the transcriptional targets of Eomes during acute and chronic 
infection would begin to address whether these T-box factors have conserved activity 
with situational manifestations or context dependent activity. Two approaches could 
prove to be fruitful in addressing this question. First, chromatin immunoprecipitation of 
Eomes from antiviral CD8+ T cells at different stages of differentiation (effector, memory, 
and exhausted) could determine whether Eomes may regulate the same or distinct gene 
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sets in response to acutely resolved or chronic infections. While Eomes might bind to 
and thereby regulate distinct gene sets in acutely resolved and chronic viral infections, 
this differential binding could simply be a result of chromatin accessibility, not differential 
targeting. Consistent with this hypothesis, T-box transcription factors appear to have 
equal binding of consensus sequences regardless of context. For example, T-box 
factors from separate subfamilies can bind the same set of target genes (Lewis et al., 
2007), suggesting that association with potentially distinct cofactors does not limit 
binding to transcriptional targets. Similarly, T-bet has been reported to bind the same set 
of target genes in a variety of lymphocytes regardless of transcriptional activity at such 
targets (Beima et al., 2006). These findings suggest that the context dependent 
cofactors for T-box factors (such as those that vary between lymphocyte lineages) may 
not direct binding to distinct transcriptional targets, but rather may modulate the 
transcriptional activity of T-box targets. Thus, while promising, chromatin 
immunoprecipitation may be only one or several technologies that need to be employed 
to determine how T-box factors have context dependent functions. 
A complimentary approach to investigate the differential activity of Eomes in 
acutely resolved versus chronic infections would employ the Eomesgfp/+ reporter mouse 
characterized in Chapter 2. Whole genome expression profiling has been used to define 
the transcriptional signature at different stages of cellular differentiation (Ivanova et al., 
2002; Novershtern et al., 2011; Phillips et al., 2000; Wherry et al., 2007). In a similar 
manner, gene expression analysis of GFP+ and GFP- CD8+ T cells from Eomesgfp/fl mice 
with or without a CD4-Cre could not only define the transcriptional program associated 
with Eomes expression but also begin to differentiate the transcriptional program 
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activated upstream or in parallel to Eomes expression from the set of genes that are 
regulated downstream of Eomes. 
Specifically, the set of differentially expressed genes between GFP+ and GFP- 
Eomesgfp/+ CD8+ T cells would comprise the transcriptional network associated with 
Eomes expression, however, this gene set is a combination of genes that are activated 
upstream or in parallel to Eomes transcription and genes that are directly regulated or 
downstream of Eomes transcriptional activity. Transcriptional profiling of GFP+ and GFP- 
Eomesgfp/- CD8+ T cells would assist in disaggregating these two gene sets. The 
differentially expressed genes between GFP+ and GFP- Eomesgfp/- CD8+ T cells would 
define the gene set activated upstream and in parallel to Eomes activation. In contrast, 
the differentially expressed gene set between GFP+ CD8+ T cells with or without Eomes 
protein would define the transcriptional program downstream of Eomes transcriptional 
activity. Disaggregating these two gene sets could illuminate new opportunities for 
therapeutic intervention in settings where Eomes activity may need to be enhanced, 
such as CD8+ T cell responses to viral infection (Banerjee et al., 2010; Intlekofer et al., 
2008; Intlekofer et al., 2005), or reduced, such as double negative T cells in ALPS 
(Kinjyo et al., 2010). 
4.4 Senescence versus Exhaustion: distinct or overlapping processes? 
Using the LCMV model of chronic viral infection, T cell exhaustion was defined 
by impaired antiviral responses, including reduced proliferation and effector functions 
(Zajac et al., 1998). The development of exhaustion is dependent on the persistence of 
antigen (Mueller and Ahmed, 2009) and displays a gradient of dysfunction that 
correlates with the length or intensity of antigen exposure (Wherry et al., 2003a). In 
addition to prolonged antigen exposure, immunoregulation is a second fundamental 
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component that limits effective and functional responses. As mentioned in Chapter 1, 
specific immunoregulatory cytokines, such as IL-10 (Brooks et al., 2008; Brooks et al., 
2006) or TGF-beta (Tinoco et al., 2009) have been reported to limit CD8+ T cell 
responses and effective viral clearance. Similarly, expression of inhibitory receptors are 
thought to impair optimal antiviral immunity, since enhanced expression of inhibitory 
receptors correlates with reduced functionality and blockade of these signaling pathways 
leads to improved T cell function. While the examination and potential reversal of CD8+ T 
cell exhaustion has largely focused on the loss of effector functions, the revival of 
proliferative capacity is a prominent feature of restored antiviral responses. Whether 
these two features are intertwined and causally linked is unclear. 
Senescence is the loss of further proliferative potential due to either telomere 
shortening or the DNA damage response to irreparable DNA, which often develops after 
a period of extensive proliferation (Akbar and Henson, 2011). Replicative senescence of 
CD8+ T cells is associated with aging, leading to poor antiviral responses in aged mice 
or humans (Akbar and Henson, 2011; Decman et al., 2010). These responses are best 
characterized by a reduced expansion in response to antigenic stimuli (Akbar and 
Henson, 2011; Decman et al., 2010), however, they also contain other dysfunctional 
features, including increased inhibitory receptor expression (Decman et al., 2012). Thus, 
senescence of CD8+ T cells share a number a features with T cell exhaustion, prompting 
speculation whether the two processes overlap.  
Consistent with this hypothesis, previous analyses of CD8+ T cells from HIV-
infected subjects revealed an elevated proliferative history as measured by T cell 
Receptor Excision Circles (Brenchley et al., 2003), markers associated with shortened 
telomeres (Brenchley et al., 2003), and elevated incorporation of deuterated glucose into 
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DNA (Hellerstein et al., 1999; Hellerstein et al., 2003; Ladell et al., 2008; McCune et al., 
2000; Mohri et al., 2001). In addition, HIV-specific CD8+ T cells have reduced 
proliferative potential in vitro after antigenic stimulation (Brenchley et al., 2003). Lastly, 
the transcriptional profiles of age-associated senescence and exhaustion share a similar 
transcriptional signature (Decman et al., 2012).  
The data presented in Chapter 3 contextualize the apparent overlap between 
replicative senescence and functional exhaustion. During chronic infection, Eomes 
expression defines a population of CD8+ T cells that display reduced effector function, 
increased inhibitory receptor expression, extensive replicative history, and reduced 
proliferative potential. This Eomeshi population constitutes the majority of the antiviral 
response during periods of high viral load when dysfunctional responses are most 
apparent. Thus, previous analysis of virus-specific CD8+ T cell populations during 
chronic infection may have principally described the Eomeshi, more terminally 
differentiated and senescent population, and likely overlooked the proliferative potential 
of the T-bethi precursor pool. 
Whether inhibitory receptor expression increases and effector functions decrease 
as a direct correlate of division history in the Eomeshi pool remains to be determined. 
Nevertheless, it is likely that extensive division history in both exhaustion and 
senescence correlates with reduced proliferative potential and effector functions. 
Whether this process is controlled by the same molecular mechanisms remains to be 
explored. 
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4.5 Divergent development of memory and exhaustion. 
In Chapter 3, a long-lived T-bethi progenitor pool was determined to sustain the 
antiviral CD8+ T cell response. How this progenitor pool develops is unclear. What has 
been demonstrated, however, is the progressive divergence of memory and exhaustion. 
CD8+ T cells appear to have equal potential for memory or exhaustion early in the 
antiviral response (day 8 post-infection) depending on the resolution or persistence of 
infection. This apparent plasticity is restricted to the memory precursor population, as 
terminal effectors do not persist in the face of persistent antigen (Angelosanto et al., 
2012); however, it remains to be determined whether (1) memory precursors are 
homogenously receptive to instructive signals associated with resolution or persistence 
of viral infection or (2) subpopulations of memory precursors are pre-programmed for 
these two distinct outcomes and respond to selective signals that result from resolution 
or persistence of infection.  
4.6 Similarities and differences between recall responses of memory and 
maintenance of exhaustion. 
A major question arising from this work is whether the continual repopulation of 
the Eomeshi pool from T-bethi precursors parallels recall responses by memory cells 
against re-exposure to cognate antigen. In the most fundamental framework, these two 
processes are quite similar. In both cases, in response to antigenic stimulation, a long-
lived precursor population contains the capacity to differentiate, proliferate, and 
(re)generate a larger, short-lived population. In addition, a lengthy and repeated 
repopulation of the short-lived pool drains the renewal and proliferative capacity of the 
long-lived population and eventually impairs future proliferative events. Thus, 
conceptually, maintenance of exhausted CD8+ T cell responses by the T-bethi precursor 
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pool parallels the essential function of long-lived memory CD8+ T cells in providing 
lifelong immunity to acutely resolved infections. 
Previous reports (West et al., 2011) in conjunction with the data presented in 
Chapter 3, however, suggest important differences between memory CD8+ T cells and 
the T-bethi precursor population during chronic infection. In particular, the relative 
responsiveness to antigen as measured by the extent of subsequent proliferation is 
markedly distinct between these two populations. In the presence of a high antigen 
burden during chronic infection, a small percentage of T-bethi precursors intermittently 
give rise to extensively divided Eomeshi progeny. While a similar phenomenon appears 
to occur with memory CD8+ T cells after a small and relatively transient encounter with 
antigen (Ciocca et al., 2012), memory cells transferred into a chronic infection almost 
uniformly proliferate extensively and display little renewal behavior. Consistent with 
impaired renewal of memory CD8+ T cells in the context of prolonged high antigen 
exposure, memory CD8+ T cells appear incapable of sustaining an antiviral response 
during a chronic viral infection when viral control is not rapidly achieved (West et al., 
2011). Thus, the T-bethi precursor population displays a resistance to antigen-induced 
activation, proliferation, and differentiation that may be essential to maintaining an 
antiviral response during chronic infection. The distinctions between these two types of 
long-lived, precursor populations may provide important avenues to prophylactically or 
therapeutically intervene in one process without altering the other. 
What determines this relative “antigen ignorance” in T-bethi precursors during 
chronic infection is not well understood. One possibility is that these precursors occupy 
select niches in the immune compartment that do not efficiently or adequately present 
viral antigens, thus providing a cell-extrinsic method to preserve antigen ignorance. A 
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second, cell-intrinsic mechanism for antigen ignorance could be down modulation of 
TCR-signaling pathways. While this second mechanism may be more appealing, how 
this would occur is unclear. Although inhibitory receptors are likely candidates to temper 
TCR signaling in the T-bethi population, these receptors are more highly expressed on 
the Eomeshi population than the T-bethi population. Thus, alternative mechanisms for 
attenuating TCR-signaling may be more likely to maintain the state of relative antigen 
ignorance of the T-bethi population. For example, the components of TCR-signaling 
pathways may be differentially expressed or differentially regulated between precursors 
and progeny. Alternatively, the distinct transcriptional status of these two populations 
may lead to distinct transcriptional responses to TCR signaling. 
Differential responsiveness to antigen receptor signaling is not unique to 
exhausted CD8+ T cells. For example, strong antigen receptor signals of developing 
single positive thymocytes or immature B cells in the bone marrow lead to negative 
selection and apoptosis. In contrast, once those cells exit the thymus or bone marrow 
and mature into naïve T or B cells in the periphery, strong antigen receptor stimuli leads 
to robust proliferation and further differentiation. How the same signaling events lead to 
dramatically distinct cellular outcomes, death or proliferation, remains unresolved. 
Similar to exhausted CD8+ T cells one hypothesis is that the signaling pathway 
downstream of the proximal signaling events may be differentially structured, leading to 
the opposing outcomes. Alternatively, the transcriptional program operating during T and 
B cell development may differentially modulate the activity of the downstream 
transcription factors, such as NFAT, NF-κB, and others. As a result, further exploration 
into the mechanisms behind the differential responses to TCR signaling in exhausted 
 
 
87 
CD8+ T cells may inform other scenarios of disparate reactions to antigen receptor 
signals. 
4.7 Does asymmetric cell division contribute to CD8+ T cell responses during 
chronic viral infection? 
In response to antigenic stimuli or other external cues, lymphocytes have been 
proposed to undergo asymmetric cell division (ACD) to generate two daughter cells with 
distinct properties and outcomes (Barnett et al., 2012; Chang et al., 2011; Chang et al., 
2007; Ciocca et al., 2012; Thaunat et al., 2012). This process is of particular relevance 
to memory lymphocytes that are required to generate a large, short-lived population for 
pathogen clearance while renewing the memory pool for lifelong immunity (Ciocca et al., 
2012). In a similar manner during chronic infection, T-bethi precursors delineated in 
Chapter 3 are required to produce daughter cells that seed the Eomeshi population while 
concurrently preserving the precursor pool. Whether exhausted CD8+ T cells employ 
ACD to preserve T-bethi precursors while repopulating Eomeshi progeny is not known. 
If ACD were one mechanism to sustain antiviral responses to chronic infections, 
one would predict that T-bethi precursors would have relatively high rates of ACD to 
simultaneously generate one cell the T-bethi pool while giving rise to a second transit 
amplifying cell that would undergo a series of subsequent symmetric divisions that would 
repopulate the Eomeshi pool. If this were the case, specific fate determinants would be 
asymmetrically distributed during this process. In particular, specific transcription factors 
that regulate exhausted CD8+ T cells could be differentially inherited, such as T-bet or 
Eomes as well as Blimp1 (Shin et al., 2009), BATF (Quigley et al., 2010), STAT3 (Siegel 
et al., 2011), NFAT (Agnellini et al., 2007), or a number of other factors upregulated in 
exhausted CD8+ T cells (Wherry et al., 2007). 
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4.8 Summary 
When the work described here was initiated, the transcriptional regulation and 
population dynamics of CD8+ T cell responses to chronic viral infections were not well 
understood. The identification of precursors and progeny in the CD8+ T cell response 
should provide a framework for future investigations into disease progression and 
immunologic manipulation during chronic infection. Even so, the work presented here 
may also emphasize how investigators should use the caution before defining a 
transcriptional program by only one or two transcription factors, as T-bet and Eomes, like 
many other transcription factors, appear to act in exquisitely context dependent 
manners.  
 
 
 
 
 
 
 
 
 
 
 
 
89 
BIBLIOGRAPHY 
 
Centers for Disease Control and Prevention (2010). Estimates of deaths associated with 
seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep 59, 
1057-1062. 
Centers for Disease Control and Prevention (2011). HIV Surveillance Report, 2009; vol. 
21. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/. Accessed July 1st, 
2012. 
Agnellini, P., Wolint, P., Rehr, M., Cahenzli, J., Karrer, U., and Oxenius, A. (2007). 
Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T 
cell functions during chronic viral infection. Proc Natl Acad Sci U S A 104, 4565-4570. 
Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M., and Oldstone, M.B. (1984). Selection of 
genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected 
mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J 
Exp Med 160, 521-540. 
Akbar, A.N., and Henson, S.M. (2011). Are senescence and exhaustion intertwined or 
unrelated processes that compromise immunity? Nat Rev Immunol 11, 289-295. 
Angelosanto, J.M., Blackburn, S.D., Crawford, A., and Wherry, E.J. (2012). Progressive 
loss of memory T cell potential and commitment to exhaustion during chronic viral 
infection. J Virol. 
Araki, K., Turner, A.P., Shaffer, V.O., Gangappa, S., Keller, S.A., Bachmann, M.F., 
Larsen, C.P., and Ahmed, R. (2009). mTOR regulates memory CD8 T-cell 
differentiation. Nature 460, 108-112. 
Arnold, S.J., Huang, G.J., Cheung, A.F., Era, T., Nishikawa, S., Bikoff, E.K., Molnar, Z., 
Robertson, E.J., and Groszer, M. (2008). The T-box transcription factor Eomes/Tbr2 
regulates neurogenesis in the cortical subventricular zone. Genes Dev 22, 2479-2484. 
Arnold, S.J., Sugnaseelan, J., Groszer, M., Srinivas, S., and Robertson, E.J. (2009). 
Generation and analysis of a mouse line harboring GFP in the Eomes/Tbr2 locus. 
Genesis 47, 775-781. 
Atreya, I., Schimanski, C.C., Becker, C., Wirtz, S., Dornhoff, H., Schnurer, E., Berger, 
M.R., Galle, P.R., Herr, W., and Neurath, M.F. (2007). The T-box transcription factor 
eomesodermin controls CD8 T cell activity and lymph node metastasis in human 
colorectal cancer. Gut 56, 1572-1578. 
Banerjee, A., Gordon, S.M., Intlekofer, A.M., Paley, M.A., Mooney, E.C., Lindsten, T., 
Wherry, E.J., and Reiner, S.L. (2010). Cutting edge: The transcription factor 
eomesodermin enables CD8+ T cells to compete for the memory cell niche. J Immunol 
185, 4988-4992. 
 
 
90 
Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H., Freeman, 
G.J., and Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic 
viral infection. Nature 439, 682-687. 
Barnett, B.E., Ciocca, M.L., Goenka, R., Barnett, L.G., Wu, J., Laufer, T.M., Burkhardt, 
J.K., Cancro, M.P., and Reiner, S.L. (2012). Asymmetric B cell division in the germinal 
center reaction. Science 335, 342-344. 
Basson, C.T., Bachinsky, D.R., Lin, R.C., Levi, T., Elkins, J.A., Soults, J., Grayzel, D., 
Kroumpouzou, E., Traill, T.A., Leblanc-Straceski, J., et al. (1997). Mutations in human 
TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat 
Genet 15, 30-35. 
Becker, T.C., Coley, S.M., Wherry, E.J., and Ahmed, R. (2005). Bone marrow is a 
preferred site for homeostatic proliferation of memory CD8 T cells. J Immunol 174, 1269-
1273. 
Becker, T.C., Wherry, E.J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A., and Ahmed, 
R. (2002). Interleukin 15 is required for proliferative renewal of virus-specific memory 
CD8 T cells. J Exp Med 195, 1541-1548. 
Beeman, E.A. (2007). Charles Armstrong M.D.: A biography (Office of History, 
National Institutes of Health). 
Beima, K.M., Miazgowicz, M.M., Lewis, M.D., Yan, P.S., Huang, T.H., and Weinmann, 
A.S. (2006). T-bet binding to newly identified target gene promoters is cell type-
independent but results in variable context-dependent functional effects. J Biol Chem 
281, 11992-12000. 
Blackburn, S.D., Crawford, A., Shin, H., Polley, A., Freeman, G.J., and Wherry, E.J. 
(2010). Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral 
infection: implications for CD8 T-cell exhaustion. J Virol 84, 2078-2089. 
Blackburn, S.D., Shin, H., Freeman, G.J., and Wherry, E.J. (2008). Selective expansion 
of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc Natl Acad Sci U S 
A 105, 15016-15021. 
Blackburn, S.D., Shin, H., Haining, W.N., Zou, T., Workman, C.J., Polley, A., Betts, M.R., 
Freeman, G.J., Vignali, D.A., and Wherry, E.J. (2009). Coregulation of CD8+ T cell 
exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10, 
29-37. 
Blattman, J.N., Wherry, E.J., Ha, S.J., van der Most, R.G., and Ahmed, R. (2009). 
Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic 
infection. J Virol 83, 4386-4394. 
Bongers, E.M., Duijf, P.H., van Beersum, S.E., Schoots, J., Van Kampen, A., 
Burckhardt, A., Hamel, B.C., Losan, F., Hoefsloot, L.H., Yntema, H.G., et al. (2004). 
 
 
91 
Mutations in the human TBX4 gene cause small patella syndrome. Am J Hum Genet 74, 
1239-1248. 
Borrow, P., and Oldstone, M.B. (1992). Characterization of lymphocytic choriomeningitis 
virus-binding protein(s): a candidate cellular receptor for the virus. J Virol 66, 7270-7281. 
Brahmer, J.R., Tykodi, S.S., Chow, L.Q., Hwu, W.J., Topalian, S.L., Hwu, P., Drake, 
C.G., Camacho, L.H., Kauh, J., Odunsi, K., et al. (2012). Safety and Activity of Anti-PD-
L1 Antibody in Patients with Advanced Cancer. N Engl J Med. 
Brenchley, J.M., Karandikar, N.J., Betts, M.R., Ambrozak, D.R., Hill, B.J., Crotty, L.E., 
Casazza, J.P., Kuruppu, J., Migueles, S.A., Connors, M., et al. (2003). Expression of 
CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T 
cells. Blood 101, 2711-2720. 
Brooks, D.G., Ha, S.J., Elsaesser, H., Sharpe, A.H., Freeman, G.J., and Oldstone, M.B. 
(2008). IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity 
during persistent viral infection. Proc Natl Acad Sci U S A 105, 20428-20433. 
Brooks, D.G., Trifilo, M.J., Edelmann, K.H., Teyton, L., McGavern, D.B., and Oldstone, 
M.B. (2006). Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 
12, 1301-1309. 
Buchbinder, S.P., Mehrotra, D.V., Duerr, A., Fitzgerald, D.W., Mogg, R., Li, D., Gilbert, 
P.B., Lama, J.R., Marmor, M., Del Rio, C., et al. (2008). Efficacy assessment of a cell-
mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, 
placebo-controlled, test-of-concept trial. Lancet 372, 1881-1893. 
Butler, N.S., Moebius, J., Pewe, L.L., Traore, B., Doumbo, O.K., Tygrett, L.T., 
Waldschmidt, T.J., Crompton, P.D., and Harty, J.T. (2011). Therapeutic blockade of PD-
L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol 
13, 188-195. 
Butz, E.A., and Bevan, M.J. (1998). Massive expansion of antigen-specific CD8+ T cells 
during an acute virus infection. Immunity 8, 167-175. 
Cao, W., Henry, M.D., Borrow, P., Yamada, H., Elder, J.H., Ravkov, E.V., Nichol, S.T., 
Compans, R.W., Campbell, K.P., and Oldstone, M.B. (1998). Identification of alpha-
dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. 
Science 282, 2079-2081. 
Casazza, J.P., Betts, M.R., Picker, L.J., and Koup, R.A. (2001). Decay kinetics of human 
immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly 
active antiretroviral therapy. J Virol 75, 6508-6516. 
Chang, J.T., Ciocca, M.L., Kinjyo, I., Palanivel, V.R., McClurkin, C.E., Dejong, C.S., 
Mooney, E.C., Kim, J.S., Steinel, N.C., Oliaro, J., et al. (2011). Asymmetric proteasome 
segregation as a mechanism for unequal partitioning of the transcription factor T-bet 
during T lymphocyte division. Immunity 34, 492-504. 
 
 
92 
Chang, J.T., Palanivel, V.R., Kinjyo, I., Schambach, F., Intlekofer, A.M., Banerjee, A., 
Longworth, S.A., Vinup, K.E., Mrass, P., Oliaro, J., et al. (2007). Asymmetric T 
lymphocyte division in the initiation of adaptive immune responses. Science 315, 1687-
1691. 
Chang, L.Y., Chang, I.S., Chen, W.J., Huang, Y.C., Chen, G.W., Shih, S.R., Juang, J.L., 
Shih, H.M., Hsiung, C.A., Lin, T.Y., and Huang, L.M. (2008). HLA-A33 is associated with 
susceptibility to enterovirus 71 infection. Pediatrics 122, 1271-1276. 
Chapman, S.J., and Hill, A.V. (2012). Human genetic susceptibility to infectious disease. 
Nat Rev Genet 13, 175-188. 
Chen, T., Heller, E., Beronja, S., Oshimori, N., Stokes, N., and Fuchs, E. (2012). An 
RNA interference screen uncovers a new molecule in stem cell self-renewal and long-
term regeneration. Nature 485, 104-108. 
Cho, O.H., Shin, H.M., Miele, L., Golde, T.E., Fauq, A., Minter, L.M., and Osborne, B.A. 
(2009). Notch regulates cytolytic effector function in CD8+ T cells. J Immunol 182, 3380-
3389. 
Choo, D.K., Murali-Krishna, K., Anita, R., and Ahmed, R. (2010). Homeostatic turnover 
of virus-specific memory CD8 T cells occurs stochastically and is independent of CD4 T 
cell help. J Immunol 185, 3436-3444. 
Ciocca, M.L., Barnett, B.E., Burkhardt, J.K., Chang, J.T., and Reiner, S.L. (2012). 
Cutting edge: asymmetric memory T cell division in response to rechallenge. J Immunol 
188, 4145-4148. 
Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C., and Lusso, P. 
(1995). Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-
suppressive factors produced by CD8+ T cells. Science 270, 1811-1815. 
Cruz-Guilloty, F., Pipkin, M.E., Djuretic, I.M., Levanon, D., Lotem, J., Lichtenheld, M.G., 
Groner, Y., and Rao, A. (2009). Runx3 and T-box proteins cooperate to establish the 
transcriptional program of effector CTLs. J Exp Med 206, 51-59. 
Day, C.L., Kaufmann, D.E., Kiepiela, P., Brown, J.A., Moodley, E.S., Reddy, S., Mackey, 
E.W., Miller, J.D., Leslie, A.J., DePierres, C., et al. (2006). PD-1 expression on HIV-
specific T cells is associated with T-cell exhaustion and disease progression. Nature 
443, 350-354. 
Decman, V., Laidlaw, B.J., Dimenna, L.J., Abdulla, S., Mozdzanowska, K., Erikson, J., 
Ertl, H.C., and Wherry, E.J. (2010). Cell-intrinsic defects in the proliferative response of 
antiviral memory CD8 T cells in aged mice upon secondary infection. J Immunol 184, 
5151-5159. 
Decman, V., Laidlaw, B.J., Doering, T.A., Leng, J., Ertl, H.C., Goldstein, D.R., and 
Wherry, E.J. (2012). Defective CD8 T cell responses in aged mice are due to 
 
 
93 
quantitative and qualitative changes in virus-specific precursors. J Immunol 188, 1933-
1941. 
Diskin, R., Scheid, J.F., Marcovecchio, P.M., West, A.P., Jr., Klein, F., Gao, H., 
Gnanapragasam, P.N., Abadir, A., Seaman, M.S., Nussenzweig, M.C., and Bjorkman, 
P.J. (2011). Increasing the potency and breadth of an HIV antibody by using structure-
based rational design. Science 334, 1289-1293. 
Dorman, S.E., Uzel, G., Roesler, J., Bradley, J.S., Bastian, J., Billman, G., King, S., Filie, 
A., Schermerhorn, J., and Holland, S.M. (1999). Viral infections in interferon-gamma 
receptor deficiency. J Pediatr 135, 640-643. 
Du Pasquier, R.A., Kuroda, M.J., Zheng, Y., Jean-Jacques, J., Letvin, N.L., and Koralnik, 
I.J. (2004). A prospective study demonstrates an association between JC virus-specific 
cytotoxic T lymphocytes and the early control of progressive multifocal 
leukoencephalopathy. Brain 127, 1970-1978. 
Dutton, R.W., Bradley, L.M., and Swain, S.L. (1998). T cell memory. Annu Rev Immunol 
16, 201-223. 
Ejrnaes, M., Filippi, C.M., Martinic, M.M., Ling, E.M., Togher, L.M., Crotty, S., and von 
Herrath, M.G. (2006). Resolution of a chronic viral infection after interleukin-10 receptor 
blockade. J Exp Med 203, 2461-2472. 
Elsaesser, H., Sauer, K., and Brooks, D.G. (2009). IL-21 is required to control chronic 
viral infection. Science 324, 1569-1572. 
Endo, Y., Iwamura, C., Kuwahara, M., Suzuki, A., Sugaya, K., Tumes, D.J., Tokoyoda, 
K., Hosokawa, H., Yamashita, M., and Nakayama, T. (2011). Eomesodermin Controls 
Interleukin-5 Production in Memory T Helper 2 Cells through Inhibition of Activity of the 
Transcription Factor GATA3. Immunity 35, 733-745. 
Finotto, S., Neurath, M.F., Glickman, J.N., Qin, S., Lehr, H.A., Green, F.H., Ackerman, 
K., Haley, K., Galle, P.R., Szabo, S.J., et al. (2002). Development of spontaneous airway 
changes consistent with human asthma in mice lacking T-bet. Science 295, 336-338. 
Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales, F.L., Jr., 
Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002). Peginterferon alfa-2a 
plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347, 975-982. 
Frohlich, A., Kisielow, J., Schmitz, I., Freigang, S., Shamshiev, A.T., Weber, J., 
Marsland, B.J., Oxenius, A., and Kopf, M. (2009). IL-21R on T cells is critical for 
sustained functionality and control of chronic viral infection. Science 324, 1576-1580. 
Gao, Y., Tao, J., Li, M.O., Zhang, D., Chi, H., Henegariu, O., Kaech, S.M., Davis, R.J., 
Flavell, R.A., and Yin, Z. (2005). JNK1 is essential for CD8+ T cell-mediated tumor 
immune surveillance. J Immunol 175, 5783-5789. 
 
 
94 
Giorgi, J.V., Hultin, L.E., McKeating, J.A., Johnson, T.D., Owens, B., Jacobson, L.P., 
Shih, R., Lewis, J., Wiley, D.J., Phair, J.P., et al. (1999). Shorter survival in advanced 
human immunodeficiency virus type 1 infection is more closely associated with T 
lymphocyte activation than with plasma virus burden or virus chemokine coreceptor 
usage. J Infect Dis 179, 859-870. 
Goldrath, A.W., Sivakumar, P.V., Glaccum, M., Kennedy, M.K., Bevan, M.J., Benoist, C., 
Mathis, D., and Butz, E.A. (2002). Cytokine requirements for acute and Basal 
homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 195, 1515-
1522. 
Gordon, S.M., Carty, S.A., Kim, J.S., Zou, T., Smith-Garvin, J., Alonzo, E.S., Haimm, E., 
Sant'Angelo, D.B., Koretzky, G.A., Reiner, S.L., and Jordan, M.S. (2011). Requirements 
for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-
like CD8+ T cells. J Immunol 186, 4573-4578. 
Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., Lindsten, T., and 
Reiner, S.L. (2012). The transcription factors T-bet and Eomes control key checkpoints 
of natural killer cell maturation. Immunity 36, 55-67. 
Gougeon, M.L., Lecoeur, H., Dulioust, A., Enouf, M.G., Crouvoiser, M., Goujard, C., 
Debord, T., and Montagnier, L. (1996). Programmed cell death in peripheral 
lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 
and CD8 T cells correlates with lymphocyte activation and with disease progression. J 
Immunol 156, 3509-3520. 
Grakoui, A., Shoukry, N.H., Woollard, D.J., Han, J.H., Hanson, H.L., Ghrayeb, J., 
Murthy, K.K., Rice, C.M., and Walker, C.M. (2003). HCV persistence and immune 
evasion in the absence of memory T cell help. Science 302, 659-662. 
Guidotti, L.G., and Chisari, F.V. (1996). To kill or to cure: options in host defense against 
viral infection. Curr Opin Immunol 8, 478-483. 
Hansen, S.G., Ford, J.C., Lewis, M.S., Ventura, A.B., Hughes, C.M., Coyne-Johnson, L., 
Whizin, N., Oswald, K., Shoemaker, R., Swanson, T., et al. (2011). Profound early 
control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473, 523-
527. 
Hazenberg, M.D., Stuart, J.W., Otto, S.A., Borleffs, J.C., Boucher, C.A., de Boer, R.J., 
Miedema, F., and Hamann, D. (2000). T-cell division in human immunodeficiency virus 
(HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients 
before and during highly active antiretroviral therapy (HAART). Blood 95, 249-255. 
He, Y.L., Zhao, Y.R., Zhang, S.L., and Lin, S.M. (2006). Host susceptibility to persistent 
hepatitis B virus infection. World J Gastroenterol 12, 4788-4793. 
Hegel, J.K., Knieke, K., Kolar, P., Reiner, S.L., and Brunner-Weinzierl, M.C. (2009). 
CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing 
Eomesodermin. Eur J Immunol 39, 883-893. 
 
 
95 
Hellerstein, M., Hanley, M.B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., 
Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999). Directly measured kinetics 
of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med 5, 83-89. 
Hellerstein, M.K., Hoh, R.A., Hanley, M.B., Cesar, D., Lee, D., Neese, R.A., and 
McCune, J.M. (2003). Subpopulations of long-lived and short-lived T cells in advanced 
HIV-1 infection. J Clin Invest 112, 956-966. 
Hersperger, A.R., Martin, J.N., Shin, L.Y., Sheth, P.M., Kovacs, C.M., Cosma, G.L., 
Makedonas, G., Pereyra, F., Walker, B.D., Kaul, R., et al. (2011). Increased HIV-specific 
CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet 
expression. Blood 117, 3799-3808. 
Hertoghs, K.M., Moerland, P.D., van Stijn, A., Remmerswaal, E.B., Yong, S.L., van de 
Berg, P.J., van Ham, S.M., Baas, F., ten Berge, I.J., and van Lier, R.A. (2010). Molecular 
profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 
120, 4077-4090. 
Hinrichs, C.S., Spolski, R., Paulos, C.M., Gattinoni, L., Kerstann, K.W., Palmer, D.C., 
Klebanoff, C.A., Rosenberg, S.A., Leonard, W.J., and Restifo, N.P. (2008). IL-2 and IL-
21 confer opposing differentiation programs to CD8+ T cells for adoptive 
immunotherapy. Blood 111, 5326-5333. 
Hodge, R.D., Nelson, B.R., Kahoud, R.J., Yang, R., Mussar, K.E., Reiner, S.L., and 
Hevner, R.F. (2012). Tbr2 is essential for hippocampal lineage progression from neural 
stem cells to intermediate progenitors and neurons. J Neurosci 32, 6275-6287. 
Intlekofer, A.M., Banerjee, A., Takemoto, N., Gordon, S.M., Dejong, C.S., Shin, H., 
Hunter, C.A., Wherry, E.J., Lindsten, T., and Reiner, S.L. (2008). Anomalous type 17 
response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 
321, 408-411. 
Intlekofer, A.M., Takemoto, N., Kao, C., Banerjee, A., Schambach, F., Northrop, J.K., 
Shen, H., Wherry, E.J., and Reiner, S.L. (2007). Requirement for T-bet in the aberrant 
differentiation of unhelped memory CD8+ T cells. J Exp Med 204, 2015-2021. 
Intlekofer, A.M., Takemoto, N., Wherry, E.J., Longworth, S.A., Northrup, J.T., Palanivel, 
V.R., Mullen, A.C., Gasink, C.R., Kaech, S.M., Miller, J.D., et al. (2005). Effector and 
memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6, 1236-
1244. 
Ivanova, N.B., Dimos, J.T., Schaniel, C., Hackney, J.A., Moore, K.A., and Lemischka, 
I.R. (2002). A stem cell molecular signature. Science 298, 601-604. 
Jamieson, B.D., Butler, L.D., and Ahmed, R. (1987). Effective clearance of a persistent 
viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific 
bone marrow-derived cells. J Virol 61, 3930-3937. 
 
 
96 
Jin, H.T., Anderson, A.C., Tan, W.G., West, E.E., Ha, S.J., Araki, K., Freeman, G.J., 
Kuchroo, V.K., and Ahmed, R. (2010). Cooperation of Tim-3 and PD-1 in CD8 T-cell 
exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 107, 14733-14738. 
Jin, X., Bauer, D.E., Tuttleton, S.E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C.E., 
Safrit, J.T., Mittler, J., Weinberger, L., et al. (1999). Dramatic rise in plasma viremia after 
CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 
189, 991-998. 
Jordan, M.B., Hildeman, D., Kappler, J., and Marrack, P. (2004). An animal model of 
hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are 
essential for the disorder. Blood 104, 735-743. 
Joshi, N.S., Cui, W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L., and 
Kaech, S.M. (2007). Inflammation directs memory precursor and short-lived effector 
CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 
281-295. 
Kaech, S.M., Tan, J.T., Wherry, E.J., Konieczny, B.T., Surh, C.D., and Ahmed, R. 
(2003). Selective expression of the interleukin 7 receptor identifies effector CD8 T cells 
that give rise to long-lived memory cells. Nat Immunol 4, 1191-1198. 
Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K.J., Podack, E.R., 
Zinkernagel, R.M., and Hengartner, H. (1994a). Cytotoxicity mediated by T cells and 
natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37. 
Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, 
H., and Golstein, P. (1994b). Fas and perforin pathways as major mechanisms of T cell-
mediated cytotoxicity. Science 265, 528-530. 
Kao, C., Oestreich, K.J., Paley, M.A., Crawford, A., Angelosanto, J.M., Ali, M.A., 
Intlekofer, A.M., Boss, J.M., Reiner, S.L., Weinmann, A.S., and Wherry, E.J. (2011). 
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and 
sustains virus-specific CD8+ T cell responses during chronic infection. Nat Immunol 12, 
663-671. 
Kasprowicz, V., Schulze Zur Wiesch, J., Kuntzen, T., Nolan, B.E., Longworth, S., 
Berical, A., Blum, J., McMahon, C., Reyor, L.L., Elias, N., et al. (2008). High level of PD-
1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute 
HCV infection, irrespective of clinical outcome. J Virol 82, 3154-3160. 
Kawamura, A., Koshida, S., and Takada, S. (2008). Activator-to-repressor conversion of 
T-box transcription factors by the Ripply family of Groucho/TLE-associated mediators. 
Mol Cell Biol 28, 3236-3244. 
Kinjyo, I., Gordon, S.M., Intlekofer, A.M., Dowdell, K., Mooney, E.C., Caricchio, R., 
Grupp, S.A., Teachey, D.T., Rao, V.K., Lindsten, T., and Reiner, S.L. (2010). Cutting 
edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription 
factor eomesodermin. J Immunol 185, 7151-7155. 
 
 
97 
Klavinskis, L.S., Geckeler, R., and Oldstone, M.B. (1989). Cytotoxic T lymphocyte 
control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not 
tumour necrosis factor alpha, displays antiviral activity in vivo. J Gen Virol 70 ( Pt 12), 
3317-3325. 
Koch, U., and Radtke, F. (2011). Mechanisms of T cell development and transformation. 
Annu Rev Cell Dev Biol 27, 539-562. 
Kogawa, K., Lee, S.M., Villanueva, J., Marmer, D., Sumegi, J., and Filipovich, A.H. 
(2002). Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic 
lymphohistiocytosis and their family members. Blood 99, 61-66. 
Kwon, G.S., and Hadjantonakis, A.K. (2007). Eomes::GFP-a tool for live imaging cells of 
the trophoblast, primitive streak, and telencephalon in the mouse embryo. Genesis 45, 
208-217. 
Ladell, K., Hellerstein, M.K., Cesar, D., Busch, R., Boban, D., and McCune, J.M. (2008). 
Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance 
as a function of HIV disease progression. J Immunol 180, 7907-7918. 
Lau, L.L., Jamieson, B.D., Somasundaram, T., and Ahmed, R. (1994). Cytotoxic T-cell 
memory without antigen. Nature 369, 648-652. 
Lechner, F., Gruener, N.H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A.R., 
Cerny, A., Phillips, R., Ferrari, C., Pape, G.R., and Klenerman, P. (2000). CD8+ T 
lymphocyte responses are induced during acute hepatitis C virus infection but are not 
sustained. Eur J Immunol 30, 2479-2487. 
Leist, T.P., Eppler, M., and Zinkernagel, R.M. (1989). Enhanced virus replication and 
inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated 
mice. J Virol 63, 2813-2819. 
Lewis, D.E., Tang, D.S., Adu-Oppong, A., Schober, W., and Rodgers, J.R. (1994). 
Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol 153, 412-
420. 
Lewis, M.D., Miller, S.A., Miazgowicz, M.M., Beima, K.M., and Weinmann, A.S. (2007). 
T-bet's ability to regulate individual target genes requires the conserved T-box domain to 
recruit histone methyltransferase activity and a separate family member-specific 
transactivation domain. Mol Cell Biol 27, 8510-8521. 
Li, Q.Y., Newbury-Ecob, R.A., Terrett, J.A., Wilson, D.I., Curtis, A.R., Yi, C.H., Gebuhr, 
T., Bullen, P.J., Robson, S.C., Strachan, T., et al. (1997). Holt-Oram syndrome is caused 
by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 15, 21-29. 
Lowin, B., Hahne, M., Mattmann, C., and Tschopp, J. (1994). Cytolytic T-cell cytotoxicity 
is mediated through perforin and Fas lytic pathways. Nature 370, 650-652. 
 
 
98 
Lugo-Villarino, G., Maldonado-Lopez, R., Possemato, R., Penaranda, C., and Glimcher, 
L.H. (2003). T-bet is required for optimal production of IFN-gamma and antigen-specific 
T cell activation by dendritic cells. Proc Natl Acad Sci U S A 100, 7749-7754. 
Ly, K.N., Xing, J., Klevens, R.M., Jiles, R.B., Ward, J.W., and Holmberg, S.D. (2012). 
The increasing burden of mortality from viral hepatitis in the United States between 1999 
and 2007. Ann Intern Med 156, 271-278. 
Lynch, H.E., Goldberg, G.L., Chidgey, A., Van den Brink, M.R., Boyd, R., and 
Sempowski, G.D. (2009). Thymic involution and immune reconstitution. Trends Immunol 
30, 366-373. 
Macintyre, A.N., Finlay, D., Preston, G., Sinclair, L.V., Waugh, C.M., Tamas, P., Feijoo, 
C., Okkenhaug, K., and Cantrell, D.A. (2011). Protein kinase B controls transcriptional 
programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. 
Immunity 34, 224-236. 
Manjunath, N., Shankar, P., Wan, J., Weninger, W., Crowley, M.A., Hieshima, K., 
Springer, T.A., Fan, X., Shen, H., Lieberman, J., and von Andrian, U.H. (2001). Effector 
differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J 
Clin Invest 108, 871-878. 
Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Shiffman, M., Reindollar, 
R., Goodman, Z.D., Koury, K., Ling, M., and Albrecht, J.K. (2001). Peginterferon alfa-2b 
plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic 
hepatitis C: a randomised trial. Lancet 358, 958-965. 
Matloubian, M., Concepcion, R.J., and Ahmed, R. (1994). CD4+ T cells are required to 
sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68, 8056-
8063. 
Matloubian, M., Kolhekar, S.R., Somasundaram, T., and Ahmed, R. (1993). Molecular 
determinants of macrophage tropism and viral persistence: importance of single amino 
acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J 
Virol 67, 7340-7349. 
Matloubian, M., Somasundaram, T., Kolhekar, S.R., Selvakumar, R., and Ahmed, R. 
(1990). Genetic basis of viral persistence: single amino acid change in the viral 
glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. J 
Exp Med 172, 1043-1048. 
Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., 
Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010). Tumor-infiltrating NY-ESO-1-
specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian 
cancer. Proc Natl Acad Sci U S A 107, 7875-7880. 
McCune, J.M., Hanley, M.B., Cesar, D., Halvorsen, R., Hoh, R., Schmidt, D., Wieder, E., 
Deeks, S., Siler, S., Neese, R., and Hellerstein, M. (2000). Factors influencing T-cell 
turnover in HIV-1-seropositive patients. J Clin Invest 105, R1-8. 
 
 
99 
McHutchison, J.G., Gordon, S.C., Schiff, E.R., Shiffman, M.L., Lee, W.M., Rustgi, V.K., 
Goodman, Z.D., Ling, M.H., Cort, S., and Albrecht, J.K. (1998). Interferon alfa-2b alone 
or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis 
Interventional Therapy Group. N Engl J Med 339, 1485-1492. 
McHutchison, J.G., Lawitz, E.J., Shiffman, M.L., Muir, A.J., Galler, G.W., McCone, J., 
Nyberg, L.M., Lee, W.M., Ghalib, R.H., Schiff, E.R., et al. (2009). Peginterferon alfa-2b 
or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 361, 580-593. 
McMahan, R.H., Golden-Mason, L., Nishimura, M.I., McMahon, B.J., Kemper, M., Allen, 
T.M., Gretch, D.R., and Rosen, H.R. (2010). Tim-3 expression on PD-1+ HCV-specific 
human CTLs is associated with viral persistence, and its blockade restores hepatocyte-
directed in vitro cytotoxicity. J Clin Invest 120, 4546-4557. 
Meyaard, L., Otto, S.A., Jonker, R.R., Mijnster, M.J., Keet, R.P., and Miedema, F. 
(1992). Programmed death of T cells in HIV-1 infection. Science 257, 217-219. 
Micallef, J.M., Kaldor, J.M., and Dore, G.J. (2006). Spontaneous viral clearance 
following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral 
Hepat 13, 34-41. 
Migueles, S.A., Laborico, A.C., Shupert, W.L., Sabbaghian, M.S., Rabin, R., Hallahan, 
C.W., Van Baarle, D., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002). HIV-
specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in 
nonprogressors. Nat Immunol 3, 1061-1068. 
Mohri, H., Perelson, A.S., Tung, K., Ribeiro, R.M., Ramratnam, B., Markowitz, M., Kost, 
R., Hurley, A., Weinberger, L., Cesar, D., et al. (2001). Increased turnover of T 
lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 
194, 1277-1287. 
Moskophidis, D., Cobbold, S.P., Waldmann, H., and Lehmann-Grube, F. (1987). 
Mechanism of recovery from acute virus infection: treatment of lymphocytic 
choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T 
lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J 
Virol 61, 1867-1874. 
Mueller, S.N., and Ahmed, R. (2009). High antigen levels are the cause of T cell 
exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 106, 8623-8628. 
Murali-Krishna, K., Altman, J.D., Suresh, M., Sourdive, D.J., Zajac, A.J., Miller, J.D., 
Slansky, J., and Ahmed, R. (1998). Counting antigen-specific CD8 T cells: a 
reevaluation of bystander activation during viral infection. Immunity 8, 177-187. 
Murali-Krishna, K., Lau, L.L., Sambhara, S., Lemonnier, F., Altman, J., and Ahmed, R. 
(1999). Persistence of memory CD8 T cells in MHC class I-deficient mice. Science 286, 
1377-1381. 
 
 
100
Naiche, L.A., Harrelson, Z., Kelly, R.G., and Papaioannou, V.E. (2005). T-box genes in 
vertebrate development. Annu Rev Genet 39, 219-239. 
Nakamoto, N., Cho, H., Shaked, A., Olthoff, K., Valiga, M.E., Kaminski, M., Gostick, E., 
Price, D.A., Freeman, G.J., Wherry, E.J., and Chang, K.M. (2009). Synergistic reversal 
of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. 
PLoS Pathog 5, e1000313. 
Nakamoto, N., Kaplan, D.E., Coleclough, J., Li, Y., Valiga, M.E., Kaminski, M., Shaked, 
A., Olthoff, K., Gostick, E., Price, D.A., et al. (2008). Functional restoration of HCV-
specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and 
compartmentalization. Gastroenterology 134, 1927-1937, 1937 e1921-1922. 
Nansen, A., Jensen, T., Christensen, J.P., Andreasen, S.O., Ropke, C., Marker, O., and 
Thomsen, A.R. (1999). Compromised virus control and augmented perforin-mediated 
immunopathology in IFN-gamma-deficient mice infected with lymphocytic 
choriomeningitis virus. J Immunol 163, 6114-6122. 
Novershtern, N., Subramanian, A., Lawton, L.N., Mak, R.H., Haining, W.N., McConkey, 
M.E., Habib, N., Yosef, N., Chang, C.Y., Shay, T., et al. (2011). Densely interconnected 
transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296-309. 
Oestreich, K.J., Huang, A.C., and Weinmann, A.S. (2011). The lineage-defining factors 
T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J Exp Med 208, 
1001-1013. 
Oestreich, K.J., Mohn, S.E., and Weinmann, A.S. (2012). Molecular mechanisms that 
control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-
like gene profile. Nat Immunol 13, 405-411. 
Pachlopnik Schmid, J., Ho, C.H., Chretien, F., Lefebvre, J.M., Pivert, G., Kosco-Vilbois, 
M., Ferlin, W., Geissmann, F., Fischer, A., and de Saint Basile, G. (2009). Neutralization 
of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-
deficient mice. EMBO Mol Med 1, 112-124. 
Pearce, E.L., Mullen, A.C., Martins, G.A., Krawczyk, C.M., Hutchins, A.S., Zediak, V.P., 
Banica, M., DiCioccio, C.B., Gross, D.A., Mao, C.A., et al. (2003). Control of effector 
CD8+ T cell function by the transcription factor Eomesodermin. Science 302, 1041-1043. 
Pellegrini, M., Calzascia, T., Toe, J.G., Preston, S.P., Lin, A.E., Elford, A.R., Shahinian, 
A., Lang, P.A., Lang, K.S., Morre, M., et al. (2011). IL-7 engages multiple mechanisms to 
overcome chronic viral infection and limit organ pathology. Cell 144, 601-613. 
Persechini, P.M., Young, J.D., and Almers, W. (1990). Membrane channel formation by 
the lymphocyte pore-forming protein: comparison between susceptible and resistant 
target cells. J Cell Biol 110, 2109-2116. 
 
 
101
Pham, N.L., Badovinac, V.P., and Harty, J.T. (2009). A default pathway of memory CD8 
T cell differentiation after dendritic cell immunization is deflected by encounter with 
inflammatory cytokines during antigen-driven proliferation. J Immunol 183, 2337-2348. 
Phillips, R.L., Ernst, R.E., Brunk, B., Ivanova, N., Mahan, M.A., Deanehan, J.K., Moore, 
K.A., Overton, G.C., and Lemischka, I.R. (2000). The genetic program of hematopoietic 
stem cells. Science 288, 1635-1640. 
Piacenti, F.J. (2006). An update and review of antiretroviral therapy. Pharmacotherapy 
26, 1111-1133. 
Pipkin, M.E., Sacks, J.A., Cruz-Guilloty, F., Lichtenheld, M.G., Bevan, M.J., and Rao, A. 
(2010). Interleukin-2 and inflammation induce distinct transcriptional programs that 
promote the differentiation of effector cytolytic T cells. Immunity 32, 79-90. 
Qui, H.Z., Hagymasi, A.T., Bandyopadhyay, S., St Rose, M.C., Ramanarasimhaiah, R., 
Menoret, A., Mittler, R.S., Gordon, S.M., Reiner, S.L., Vella, A.T., and Adler, A.J. (2011). 
CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To 
Program Cytotoxic Th1 Differentiation. J Immunol. 
Quigley, M., Pereyra, F., Nilsson, B., Porichis, F., Fonseca, C., Eichbaum, Q., Julg, B., 
Jesneck, J.L., Brosnahan, K., Imam, S., et al. (2010). Transcriptional analysis of HIV-
specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat 
Med 16, 1147-1151. 
Rao, R.R., Li, Q., Odunsi, K., and Shrikant, P.A. (2010). The mTOR kinase determines 
effector versus memory CD8+ T cell fate by regulating the expression of transcription 
factors T-bet and Eomesodermin. Immunity 32, 67-78. 
Raziorrouh, B., Schraut, W., Gerlach, T., Nowack, D., Gruner, N.H., Ulsenheimer, A., 
Zachoval, R., Wachtler, M., Spannagl, M., Haas, J., et al. (2010). The immunoregulatory 
role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific 
CD8+ T-cell function. Hepatology 52, 1934-1947. 
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., 
Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009). Vaccination with 
ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361, 2209-
2220. 
Ribeiro-Dos-Santos, P., Turnbull, E.L., Monteiro, M., Legrand, A., Conrod, K., Baalwa, 
J., Pellegrino, P., Shaw, G.M., Williams, I., Borrow, P., and Rocha, B. (2012). Chronic 
HIV infection affects the expression of the two transcription factors required for CD8 T 
cells differentiation into cytolytic effectors. Blood. 
Rock, K.L., and Goldberg, A.L. (1999). Degradation of cell proteins and the generation of 
MHC class I-presented peptides. Annu Rev Immunol 17, 739-779. 
Rode, M., Balkow, S., Sobek, V., Brehm, R., Martin, P., Kersten, A., Dumrese, T., 
Stehle, T., Mullbacher, A., Wallich, R., and Simon, M.M. (2004). Perforin and Fas act 
 
 
102
together in the induction of apoptosis, and both are critical in the clearance of 
lymphocytic choriomeningitis virus infection. J Virol 78, 12395-12405. 
Rodriguez-Esteban, C., Tsukui, T., Yonei, S., Magallon, J., Tamura, K., and Izpisua 
Belmonte, J.C. (1999). The T-box genes Tbx4 and Tbx5 regulate limb outgrowth and 
identity. Nature 398, 814-818. 
Russ, A.P., Wattler, S., Colledge, W.H., Aparicio, S.A., Carlton, M.B., Pearce, J.J., 
Barton, S.C., Surani, M.A., Ryan, K., Nehls, M.C., et al. (2000). Eomesodermin is 
required for mouse trophoblast development and mesoderm formation. Nature 404, 95-
99. 
Rutishauser, R.L., Martins, G.A., Kalachikov, S., Chandele, A., Parish, I.A., Meffre, E., 
Jacob, J., Calame, K., and Kaech, S.M. (2009). Transcriptional repressor Blimp-1 
promotes CD8(+) T cell terminal differentiation and represses the acquisition of central 
memory T cell properties. Immunity 31, 296-308. 
Sachsenberg, N., Perelson, A.S., Yerly, S., Schockmel, G.A., Leduc, D., Hirschel, B., 
and Perrin, L. (1998). Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as 
measured by Ki-67 antigen. J Exp Med 187, 1295-1303. 
Sakuishi, K., Apetoh, L., Sullivan, J.M., Blazar, B.R., Kuchroo, V.K., and Anderson, A.C. 
(2010). Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore 
anti-tumor immunity. J Exp Med 207, 2187-2194. 
Salvato, M., Borrow, P., Shimomaye, E., and Oldstone, M.B. (1991). Molecular basis of 
viral persistence: a single amino acid change in the glycoprotein of lymphocytic 
choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-
lymphocyte response and establishment of persistence. J Virol 65, 1863-1869. 
Scheid, J.F., Mouquet, H., Feldhahn, N., Seaman, M.S., Velinzon, K., Pietzsch, J., Ott, 
R.G., Anthony, R.M., Zebroski, H., Hurley, A., et al. (2009). Broad diversity of 
neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 
458, 636-640. 
Scheid, J.F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T.Y., Pietzsch, 
J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011). Sequence and structural 
convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 
1633-1637. 
Schmitz, J.E., Kuroda, M.J., Santra, S., Sasseville, V.G., Simon, M.A., Lifton, M.A., 
Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B.J., et al. (1999). Control of 
viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 
857-860. 
Schroder, K., Hertzog, P.J., Ravasi, T., and Hume, D.A. (2004). Interferon-gamma: an 
overview of signals, mechanisms and functions. J Leukoc Biol 75, 163-189. 
 
 
103
Shin, H., Blackburn, S.D., Blattman, J.N., and Wherry, E.J. (2007). Viral antigen and 
extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med 
204, 941-949. 
Shin, H., Blackburn, S.D., Intlekofer, A.M., Kao, C., Angelosanto, J.M., Reiner, S.L., and 
Wherry, E.J. (2009). A role for the transcriptional repressor Blimp-1 in CD8(+) T cell 
exhaustion during chronic viral infection. Immunity 31, 309-320. 
Shoukry, N.H., Grakoui, A., Houghton, M., Chien, D.Y., Ghrayeb, J., Reimann, K.A., and 
Walker, C.M. (2003). Memory CD8+ T cells are required for protection from persistent 
hepatitis C virus infection. J Exp Med 197, 1645-1655. 
Siegel, A.M., Heimall, J., Freeman, A.F., Hsu, A.P., Brittain, E., Brenchley, J.M., Douek, 
D.C., Fahle, G.H., Cohen, J.I., Holland, S.M., and Milner, J.D. (2011). A critical role for 
STAT3 transcription factor signaling in the development and maintenance of human T 
cell memory. Immunity 35, 806-818. 
Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, 
P.A., Henter, J.I., Bennett, M., Fischer, A., de Saint Basile, G., and Kumar, V. (1999). 
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286, 
1957-1959. 
Sullivan, B.M., Emonet, S.F., Welch, M.J., Lee, A.M., Campbell, K.P., de la Torre, J.C., 
and Oldstone, M.B. (2011). Point mutation in the glycoprotein of lymphocytic 
choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-
term persistence. Proc Natl Acad Sci U S A 108, 2969-2974. 
Sullivan, B.M., Juedes, A., Szabo, S.J., von Herrath, M., and Glimcher, L.H. (2003). 
Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A 
100, 15818-15823. 
Suto, A., Wurster, A.L., Reiner, S.L., and Grusby, M.J. (2006). IL-21 inhibits IFN-gamma 
production in developing Th1 cells through the repression of Eomesodermin expression. 
J Immunol 177, 3721-3727. 
Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., and Glimcher, L.H. 
(2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 
655-669. 
Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P., and 
Glimcher, L.H. (2002). Distinct effects of T-bet in TH1 lineage commitment and IFN-
gamma production in CD4 and CD8 T cells. Science 295, 338-342. 
Takeda, K., Cretney, E., Hayakawa, Y., Ota, T., Akiba, H., Ogasawara, K., Yagita, H., 
Kinoshita, K., Okumura, K., and Smyth, M.J. (2005). TRAIL identifies immature natural 
killer cells in newborn mice and adult mouse liver. Blood 105, 2082-2089. 
 
 
104
Takemoto, N., Intlekofer, A.M., Northrup, J.T., Wherry, E.J., and Reiner, S.L. (2006). 
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during 
pathogen-induced CD8+ T cell differentiation. J Immunol 177, 7515-7519. 
Takeuchi, J.K., Koshiba-Takeuchi, K., Matsumoto, K., Vogel-Hopker, A., Naitoh-Matsuo, 
M., Ogura, K., Takahashi, N., Yasuda, K., and Ogura, T. (1999). Tbx5 and Tbx4 genes 
determine the wing/leg identity of limb buds. Nature 398, 810-814. 
Tan, J.T., Ernst, B., Kieper, W.C., LeRoy, E., Sprent, J., and Surh, C.D. (2002). 
Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory 
phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp 
Med 195, 1523-1532. 
Tao, J., Gao, Y., Li, M.O., He, W., Chen, L., Harvev, B., Davis, R.J., Flavell, R.A., and 
Yin, Z. (2007). JNK2 negatively regulates CD8+ T cell effector function and anti-tumor 
immune response. Eur J Immunol 37, 818-829. 
Tayade, C., Fang, Y., Black, G.P., V, A.P., Jr., Erlebacher, A., and Croy, B.A. (2005). 
Differential transcription of Eomes and T-bet during maturation of mouse uterine natural 
killer cells. J Leukoc Biol 78, 1347-1355. 
Thaunat, O., Granja, A.G., Barral, P., Filby, A., Montaner, B., Collinson, L., Martinez-
Martin, N., Harwood, N.E., Bruckbauer, A., and Batista, F.D. (2012). Asymmetric 
segregation of polarized antigen on B cell division shapes presentation capacity. 
Science 335, 475-479. 
Tinoco, R., Alcalde, V., Yang, Y., Sauer, K., and Zuniga, E.I. (2009). Cell-intrinsic 
transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion 
and viral persistence in vivo. Immunity 31, 145-157. 
Topalian, S.L., Hodi, F.S., Brahmer, J.R., Gettinger, S.N., Smith, D.C., McDermott, D.F., 
Powderly, J.D., Carvajal, R.D., Sosman, J.A., Atkins, M.B., et al. (2012). Safety, Activity, 
and Immune Correlates of Anti-PD-1 Antibody in Cancer. N Engl J Med. 
Townsend, M.J., Weinmann, A.S., Matsuda, J.L., Salomon, R., Farnham, P.J., Biron, 
C.A., Gapin, L., and Glimcher, L.H. (2004). T-bet regulates the terminal maturation and 
homeostasis of NK and Valpha14i NKT cells. Immunity 20, 477-494. 
Trapani, J.A., and Smyth, M.J. (2002). Functional significance of the perforin/granzyme 
cell death pathway. Nat Rev Immunol 2, 735-747. 
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T.H., 
Chennareddi, L., Silvestri, G., Freeman, G.J., et al. (2009). Enhancing SIV-specific 
immunity in vivo by PD-1 blockade. Nature 458, 206-210. 
Vezys, V., Penaloza-MacMaster, P., Barber, D.L., Ha, S.J., Konieczny, B., Freeman, 
G.J., Mittler, R.S., and Ahmed, R. (2011). 4-1BB signaling synergizes with programmed 
death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection. 
J Immunol 187, 1634-1642. 
 
 
105
Virgin, H.W., Wherry, E.J., and Ahmed, R. (2009). Redefining chronic viral infection. Cell 
138, 30-50. 
Wang, N.S., McHeyzer-Williams, L.J., Okitsu, S.L., Burris, T.P., Reiner, S.L., and 
McHeyzer-Williams, M.G. (2012). Divergent transcriptional programming of class-
specific B cell memory by T-bet and RORalpha. Nat Immunol 13, 604-611. 
Wei, C.J., Boyington, J.C., McTamney, P.M., Kong, W.P., Pearce, M.B., Xu, L., 
Andersen, H., Rao, S., Tumpey, T.M., Yang, Z.Y., and Nabel, G.J. (2010). Induction of 
broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329, 1060-1064. 
Welsch, C., Jesudian, A., Zeuzem, S., and Jacobson, I. (2012). New direct-acting 
antiviral agents for the treatment of hepatitis C virus infection and perspectives. Gut 61 
Suppl 1, i36-46. 
West, E.E., Youngblood, B., Tan, W.G., Jin, H.T., Araki, K., Alexe, G., Konieczny, B.T., 
Calpe, S., Freeman, G.J., Terhorst, C., et al. (2011). Tight regulation of memory CD8(+) 
T cells limits their effectiveness during sustained high viral load. Immunity 35, 285-298. 
Wherry, E.J. (2011). T cell exhaustion. Nat Immunol 12, 492-499. 
Wherry, E.J., Barber, D.L., Kaech, S.M., Blattman, J.N., and Ahmed, R. (2004). Antigen-
independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl 
Acad Sci U S A 101, 16004-16009. 
Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R., and Ahmed, R. 
(2003a). Viral persistence alters CD8 T-cell immunodominance and tissue distribution 
and results in distinct stages of functional impairment. J Virol 77, 4911-4927. 
Wherry, E.J., Ha, S.J., Kaech, S.M., Haining, W.N., Sarkar, S., Kalia, V., Subramaniam, 
S., Blattman, J.N., Barber, D.L., and Ahmed, R. (2007). Molecular signature of CD8+ T 
cell exhaustion during chronic viral infection. Immunity 27, 670-684. 
Wherry, E.J., Teichgraber, V., Becker, T.C., Masopust, D., Kaech, S.M., Antia, R., von 
Andrian, U.H., and Ahmed, R. (2003b). Lineage relationship and protective immunity of 
memory CD8 T cell subsets. Nat Immunol 4, 225-234. 
Wiehagen, K.R., Corbo, E., Schmidt, M., Shin, H., Wherry, E.J., and Maltzman, J.S. 
(2010). Loss of tonic T-cell receptor signals alters the generation but not the persistence 
of CD8+ memory T cells. Blood 116, 5560-5570. 
Wille, A., Gessner, A., Lother, H., and Lehmann-Grube, F. (1989). Mechanism of 
recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-
infected mice with anti-interferon-gamma monoclonal antibody blocks generation of 
virus-specific cytotoxic T lymphocytes and virus elimination. Eur J Immunol 19, 1283-
1288. 
Woo, S.R., Turnis, M.E., Goldberg, M.V., Bankoti, J., Selby, M., Nirschl, C.J., Bettini, 
M.L., Gravano, D.M., Vogel, P., Liu, C.L., et al. (2011). Immune inhibitory molecules 
 
 
106
LAG-3 and PD-1 synergistically regulate T cell function to promote tumoral immune 
escape. Cancer Res. 
Yagi, R., Junttila, I.S., Wei, G., Urban, J.F., Jr., Zhao, K., Paul, W.E., and Zhu, J. (2010). 
The transcription factor GATA3 actively represses RUNX3 protein-regulated production 
of interferon-gamma. Immunity 32, 507-517. 
Yang, Y., Xu, J., Niu, Y., Bromberg, J.S., and Ding, Y. (2008). T-bet and eomesodermin 
play critical roles in directing T cell differentiation to Th1 versus Th17. J Immunol 181, 
8700-8710. 
Yi, J.S., Du, M., and Zajac, A.J. (2009). A vital role for interleukin-21 in the control of a 
chronic viral infection. Science 324, 1572-1576. 
Yokoyama, W.M., Kim, S., and French, A.R. (2004). The dynamic life of natural killer 
cells. Annu Rev Immunol 22, 405-429. 
Zajac, A.J., Blattman, J.N., Murali-Krishna, K., Sourdive, D.J., Suresh, M., Altman, J.D., 
and Ahmed, R. (1998). Viral immune evasion due to persistence of activated T cells 
without effector function. J Exp Med 188, 2205-2213. 
Zhou, Q., Munger, M.E., Veenstra, R.G., Weigel, B.J., Hirashima, M., Munn, D.H., 
Murphy, W.J., Azuma, M., Anderson, A.C., Kuchroo, V.K., and Blazar, B.R. (2011). 
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice 
with disseminated acute myelogenous leukemia. Blood 117, 4501-4510. 
Zhou, T., Georgiev, I., Wu, X., Yang, Z.Y., Dai, K., Finzi, A., Kwon, Y.D., Scheid, J.F., 
Shi, W., Xu, L., et al. (2010). Structural basis for broad and potent neutralization of HIV-1 
by antibody VRC01. Science 329, 811-817. 
Zhu, Y., Ju, S., Chen, E., Dai, S., Li, C., Morel, P., Liu, L., Zhang, X., and Lu, B. (2010). 
T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. 
J Immunol 185, 3174-3183. 
 
 
